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Abstract
Meningitis is an inflammatory disease of the tissue surrounding the brain and spinal cord; the
lepto-meninges. Although meningitis may be caused by viral or bacterial infection, bacterial
meningitis is the most serious and notable infection of the central nervous system. It can
progress rapidly with high mortality. The detection and identification of a bacterial pathogen is
often essential to the physician in choosing appropriate antimicrobial therapy and managing
the infection. The current standard for diagnosis is a microscopic examination and culturing of
CSF. The definitive identification of a bacterium responsible for meningitis depending on CSF
culture should be obtained from patients presenting with clinical symptoms of meningitis is
essential for a successful management of meningitis. Neisseria meningitidis, Streptococcus
pneumoniae, and Haemophilus influenzae are fastidious organisms, and are the main causative
agents of bacterial meningitis, they may not survive long transit times or variations in
temperature. As laboratories are the front line for detecting bacterial meningitis, molecular
based diagnosis which is rapid and accurate, should be adapted for the detection of infectious
diseases.
This study represents a two-stage molecular approach for detection and identification of
bacterial meningitis. The first stage depends on the application of the Universal Method for
bacterial detection, the amplification of rDNA from any bacterium leading to accurate
determination of bacterial meningitis within 3 hours of sampling. In case of negative results
bacterial meningitis can be ruled out. The samples are simultaneously tested with multiplex
containing specific forward primers together with an anchored general reverse primer. The
multiplex contained four species-specific forward primers; it should detect Haemophilus
influenzae, Neisseria meningitidis, Streptococcus pneumoniae, and Listeria monocytogenes.
These can be identified based on PCR product size. This anchored multiplex was formulated
to cover the most common bacterial agents of meningitis, in case if the multiplex failed to
detect the positive cases, the Universal Method will, allowing possible identification of the
pathogen as the amplified polymerase chain reaction (PCR) product is sequenced and analyzed
using  BLAST alignment analysis.
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This work focused on the importance of early detection of bacterial meningitis using the
Universal Method developed by Barghouthi 2009. The presented approach should contribute
to better diagnosis of meningitis while saving time, reducing hospitalization days, and
increasing both specificity and sensitivity of bacterial detection, effectively enhancing
treatment of bacterial meningitis. The work presented here will increase awareness of the
progression and emergence of bacterial resistance for antibiotics in hospitals. The work may
also guide researchers and health professionals to adopt the most robust Universal Method
over the limited multiplex procedures. An important issue that was not addressed in this work
is the capacity of molecular approach to identifying markers of bacterial resistance to
antibiotics. This should be the subject of future investigations.
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1Chapter 1: Introduction
1.1 Meningitis
Meningitis, an inflammation of the meninges, the thin anatomical structure; three layers or
"membranes" that intimately and delicately cover the brain and spinal cord (Gray, 1992).
Meningitis affecting the pia, arachnoid, and subarachnoid space may be caused by bacteria or
viruses (Gray, 1992; Thomas et al., 2002). Specifically, meningitis is an infection within the
subarachnoid space, a space between the middle and innermost Layer (Gray, 1992; Kim, 2010;
Taha, 2004). Bacterial or septic meningitis and viral or aseptic must be distinguished
clinically and diagnostically (Tamimi et al., 2008). The manifestations of viral meningitis are
generally similar to those of bacterial meningitis, but less sever (Taha, 2004). Although most
infections occur in infants, the societal impact is also important because of the continued high
incidence in healthy older children and adolescents (Saravolatz et al., 2003). In spite of many
improvements in health care system, acute bacterial meningitis remains a life threatening
infectious emergency (Chakrabarti et al., 2009). Successful and adequate treatment requires
rapid detection then identification of the bacterium (Saravolatz et al., 2003). Bacterial
meningitis may lead to permanent neurological sequelae such as hearing loss, mental
retardation, seizures and behavioral changes may occur in up to 50% of survivors, especially
when the diagnosis and antibiotic administration are delayed (Dubos et al., 2008; Saravolatz et
al., 2003; Welinder-Olsson et al., 2007). Potential long-term neurological sequelae include
cranial nerve paralysis, hemi paresis, hydrocephalus, and seizures as well as visual and hearing
impairment which can have a profound impact on the quality of life of the survivors (Kim,
2003; Tebruegge and Curtis, 2008).
1.2 Bacterial meningitis:
Bacterial meningitis is the most notable infection of the central nervous system, it can progress
rapidly and may result in death or permanent debilitation (Gray, 1992; Failace et al. 2005). It
is a serious disease with high morbidity and mortality all over the world (Rafi et al., 2010;
Schuurman, et al. 2004; Ceyhan et al., 2010; Gray, 1992; Kim, 2009; Pandit et al., 2005; Rafi
2et al., 2010; Tzanakaki et al., 2005). Bacterial meningitis can be difficult to diagnose, as the
symptoms and signs are often non-specific (Rafi et al., 2010). In recent years, despite
improvements in antimicrobial therapy and intensive care support, overall mortality rates
related to bacterial meningitis were around 20% to 25% have been reported by major centers
(Tebruegge, 2008). Worldwide, an estimated 171,000 deaths are reported annually (Ceyhan et
al. 2008). Delays in initiation of antibiotic therapy can adversely affect clinical outcome
(Mishal et al., 2008). The majority of patients with bacterial meningitis survive, but
neurological sequelae occur in as many as one-third of all survivors especially newborns and
children (Gray, 1992; Ceyhan et al,. 2008). Because distinguishing between bacterial and
aseptic meningitis in the emergency department is difficult, it is recommended that antibiotics
should be started immediately in children with clinical evidence of acute meningitis
cerebrospinal fluid (CSF) and continued at least until bacterial culture results become
available 48 to 72 hours later (Dubos et al., 2008). Moreover, the culture may lead to false-
negative results when fastidious or slowly growing bacteria are involved (Chen et al., 2009).
Many studies have revealed the ability of both Gram-positive and Gram-negative bacteria to
go into a viable but non-culturable (VBNC) state (Rivers, 2001; Y. N. Sardessai, 2005). The
viable but non-culturable state is defined as one in which cells are viable yet do not undergo
sufficient division to give rise to visible growth on nonselective growth medium (Rivers,
2001) .
Figure1.1: Major anatomical features of the meninges. The meninges surrounds the brain
and spinal cord and spinal cord and is composed of three distinct layers adapted from
reference No. 28  and downloaded from the net.
31.3 Etiological agents of Bacterial meningitis:
Almost all microbes that are pathogenic to human beings have the potential to cause
meningitis, but a relatively small number of pathogens account for most cases of acute
bacterial meningitis in neonates and children, although the reasons for this association remain
incompletely understood (Kim, 2010). Determination of the etiology of bacterial meningitis
and estimating cost of disease are important in guiding vaccination policies (Ceyhan, et al.,
2008; Kaijalainen, et al., 2008). Distinguishing between bacterial and aseptic meningitis in
children in the emergency department could contribute to limiting unnecessary antibiotic use
and/or hospital admissions (Dubos, et al., 2008). The results of national surveillance studies
have shown that both the etiological agents and mortality rates (0 to 54%) of bacterial
meningitis depend on the season of the year and the age, sex, ethnic background, medical
conditions and geographic location of the patient (Chiba et al., 2009; Gray, 1992; Rafi et al.,
2010). These are heavily affected by (i) the availability of vaccination against Haemophilus
influenzae type b (Hib), Streptococcus pneumoniae, (ii) the availability of a medical
insurance system, and (iii) the hygienic and sanitary conditions (Chiba et al., 2009).
Worldwide, the three main pathogens Neisseria meningitides, Haemophilus influenzae type b
(Hib) and Streptococcus pneumoniae are the main bacterial pathogens that account for 75–
80% of cases after the neonatal period and cause invasive infections such as meningitis, sepsis
and pneumoniae in children under 5 years of age (Kaijalainen et al., 2008; Rafi et al., 2010;
Tebruegge, 2008; Tunkel, 1993). According to some studies, S. pneumoniae was the most
common causative agent accounting for 89% of all culture positive episodes, followed by H.
influenzae (6%) and N. meningitidis (4%; Gray, 1992; Tebruegge, 2008; Ceyhan et al., 2010).
1.3.1. Streptococcus pneumoniae:
Streptococcus pneumoniae is a major cause of childhood acute bacterial meningitis in
countries where vaccination against Haemophilus influenzae type b and/or meningococcal
disease has been implemented into the routine immunization schedule (Ceyhan et al., 2010).
Numerous conditions have been reported to be associated with an increased risk of
pneumococcal meningitis, including hematologic disorders, immunodeficiencies, asplenia,
4chronic renal failure, HIV infection, malnutrition, alcoholism, and head injuries (Tebruegge,
2008).
1.3.2. Neisseria meningitidis.
Several abnormalities of the immune  system have been found to predispose affected
individuals to meningitis with N. meningitidis, including immunoglobulin deficiencies
(Tebruegge, 2008). World Health Organization (WHO) reported that 430 million people at
risk of the disease in Sub-Saharan Africa’s so-called African Meningitis Belt. (Unemo et al.,
2009).
1.3.3. Haemophilus influenzae.
As a result of the widespread introduction of Hib vaccines into vaccination programs in many
industrialized countries, there has been a dramatic decline in invasive diseases caused by H.
influenzae over the last two decades (Tebruegge, 2008). H. influenzae, like N. meningitidis
and S. pneumoniae are fastidious organisms that may not survive long transit times or
variations in temperature (Gray, 1992).
1.3.4. Staphylococcus aureus.
S. aureus is a rare cause of bacterial meningitis. According to the U.S. Bacterial Meningitis
Surveillance Study, less than 1% of bacterial meningitis is caused by this bacterium
(Tebruegge, 2008).
1.3.5. Liesteria monocytogenes and other rare etiological agents:
Listeria monocytogenes was reported relatively infrequently (0.2 cases per 100,000
population) but had the highest fatality rate (22%) (Abasaeed et al., 2009). Other rare bacteria
that have been reported to cause meningitis include Acinetobacter, Bacteroides fragilis,
Achromobacterxylosoxidans, Gordona aurantiaca (Rhodococcus  aurantiacus), Lactobacillus
spp., Corynebacterium aquaticum, Streptococcus mitis, Pasteurella multocida (Gray, 1992).
5In general, the number of cases of bacterial meningitis whose etiological agent is not identified
is still significant (Failace et al., 2005).
1.3.6. Bacterial and viral meningitis in Palestine:
A study in Palestine contains additional data from the 2002 are reported in table (1.1) that
shows the distribution of etiological agents of bacterial meningitis; H. influenzae, N.
meningitidis, and other bacteria (as mentioned in the statistical epidemiological record below).
These are the leading causes of bacterial meningitis in 15 different cities in Palestine. Another
available data about viral meningitis distribution in Palestine (2005-2009) found in table
(1.2).The information was obtained by personal communications with the Ministry of health in
Palestine.
Table 1.1 Reported cases Bacterial meningitis in Palestine (2001-2002): referring to the Primary
Health Care Preventative Medicine Department in the Ministry of Health .Dr I. Arafeh
Daily notified Disease : Meningitis 2001 Cumulative Total 2002 Cumulative Total
Meningococcal meningitis 76 87
Haemophillus influenzae 9 18
Others 443 309
6Year \
District Hebron Bethlehem Ramallah Jerusalem Jericho Nablus Tulkarm Salfeet Qalqiliah Jenin Gaza Total
2005 42 25 0 10 1 23 32 4 21 11 690 859
2006 18 18 2 6 0 8 7 1 13 3 848 924
2007 120 10 8 6 0 7 17 4 38 7 913 1130
2008 180 12 21 8 2 19 53 3 55 13 192 558
2009 262 11 6 3 0 5 31 9 108 5 343 783
Before2001 Jerusalem was Include with other Districts(Beithlehem&Ramallah).
Before2009 Tubas Was Included with Jenin District.
Reported Cases Of   Viral Meningitis In Palestine, By District2005-2009
1.4 Diagnosis of bacterial meningitis:
The identification of a bacterial pathogen is often essential to the physician in choosing
appropriate antimicrobial therapy and in managing the bacterial infection meningitis (Gray,
1992; Tebruegge, 2008). The current standard for the diagnosis of bacterial meningitis is
microscopic examination and subsequent culture of cerebrospinal fluid (CSF) (Rafi et al.,
2010; Schuurman et al., 2004). However, this approach might have some disadvantages with
regard to the desired rapidity and sensitivity (Schuurman et al., 2004). Results of culture may
only be available after 48 to 72 hours which are mostly negative due to prior treatment with
antibiotics (Schuurman et al., 2004; Pandit, et al., 2005).
1.4.1. Clinical findings:
Bacterial meningitis can be difficult to diagnose, as the symptoms and signs are often non-
specific, especially in young children (Ceyhan et al., 2008; Rafi et al., 2010). Classic clinical
signs, which are present in 80% of patients, include headache, fever, and cerebral dysfunction
(confusion, delirium, or altered level of consciousness;(Mishal et al., 2008; Saravolatz et al.,
2003). However, among neonates and elderly  only subtle signs such as lethargy and
irritability may herald the onset of meningitis (Saravolatz et al., 2003). In adults, physical
findings of nuchal rigidity which is defined as the inability to flex the head forward due to
rigidity of the neck muscles with Kernig's and/or Brudzinski's signs are considered to be more
Table1.2: Reported cases of viral meningitis in Palestine (2005-2009): referring to the Primary Health
Care Preventative Medicine Department in the Ministry of Health. Dr I. Arafeh
7reliable compared to the clinical history alone, in establishing a diagnosis of bacterial
meningitis (Mishal et al., 2008; Thomas et al., 2002). Kernig’s sign which is defined as
positive when the leg is bent at the hip and knee at 90 degree angles, and subsequent further
extension in the knee is painful leading to resistance, Brudzinski’s sign which is defined as the
appearance of involuntary lifting of the legs in meningeal irritation when lifting a patient's
head off the examining couch, with the patient lying supine, and nuchal rigidity are 3 bedside
diagnostic signs used specifically to assess a patient’s risk for meningitis (Thomas et al.,
2002). These clinical signs have been used as indicators of meningeal inflammation for almost
a century (Mishal et al., 2008; Thomas et al., 2002). However, Kernig's and Brudzinski's signs
alone, without nuchal rigidity, have low sensitivity and poor diagnostic accuracy and they
should not be used as the sole determinants for further diagnostic testing (Mishal et al., 2008).
Because the consequences of delayed diagnosis of bacterial meningitis can be severe, any
proposed diagnostic tool must achieve near 100% sensitivity (Dubos et al., 2008).
Figure1.2: Bacterial meningitis diagnosis
Brudzinski neck sign:neck  rigidity-passive flexion
of both legs and thighs- Adapted from reference
No. 66
Figure 1.3 : Bacterial meningitis diagnosis Kerings
sign: patient supine, with hip flexed 90C,knee
can't be   fully extended
1.4.2. Laboratory findings:
Bacterial meningitis requires early diagnosis and empirical antimicrobial treatment
(Chakrabarti et al., 2009; Kim, 2010). CSF is widely utilized for diagnosis of diseases of the
central nervous system (CNS) (Gray, 1992). CSF has important functions; including
8cushioning the brain, maintaining a constant intracranial pressure, providing nutrients, and
removing toxic metabolites from the (CNS) (Gray, 1992; Yamamoto, 2002). Indirect
assessment of brain health status can be obtained from the CSF (Yamamoto, 2002). Since CSF
is considered germfree, detection of microbes in CSF, even in low numbers, provides valuable
information about possible infection (Yamamoto, 2002). Various laboratory investigations of
the CSF have been developed for the rapid diagnosis of acute bacterial meningitis (Pandit et
al., 2005; Yamamoto, 2002). Nevertheless, none of these tests alone or in combination are
dependable because of their poor sensitivity and specificity (Pandit et al., 2005). Bacterial
meningitis is usually suspected on the basis of the clinical presentation of the patient and the
finding of purulence in CSF (Kim, 2010; Kotilainen et al., 1998).
1.5 Conventional Methods for processing and culturing CSF:
1.5.1. Concentration:
The probabilities of detecting bacteria by culture and staining techniques are increased by
concentrating the bacteria in a CSF specimen (Gray, 1992). The number of bacteria present in
a CSF specimen from a patient with meningitis may be as few as 103 CFU/ml (Gray, 1992;
Kim, 2010). Generally, when less than 0.5 ml of CSF is received by a microbiology
laboratory, the specimen should be concentrated by centrifugation for at least 15 min at 1,500
to 2,500 x g (Murray, 1980; Gray, 1992).
1.5.2. Bacterial culture from CSF:
Currently, the diagnosis of meningitis is mostly done by CSF culture (Failace et al., 2005).
Culture is considered as the diagnostic test of choice although it is a time-consuming, it
requires viable microorganisms for cultivation, and its sensitivity  is directly affected by prior
antibiotic treatment of the patient (Saravolatz et al., 2003, Failace et al., 2005; Ray et al.,
2007). Culture remains the direct way of detecting the etiological agent of CNS bacterial
infections (Ray, 2009; Taha, 2004). Difficulties may result due to slow bacterial growth or due
to stringent growth requirements or because of prior empirical patient treatment with
9antimicrobial agents (Gray, 1992; Kim, 2010; Taha, 2004). CSF sterilization after antibiotic
use occurs rapidly, with meningococci and pneumococci disappearing within 2 and 4 hours
respectively (Rafi et al., 2010). Furthermore, 24-48 hours are required to grow visible colonies
that require further biochemical characterization (Chakrabarti et al., 2009; Rafi et al., 2010).
In an extensive study over a 27 year period, it was reported that culture might miss the
diagnosis of bacterial meningitis in at least 13% of the cases (Schuurman et al., 2004). The
cultures may be also remaining negative if the disease is caused by fastidious and/or slow
growing microorganisms (Kotilainen et al., 1998; Drancourt et al., 2000).
1.5.3. Rapid Methods for Detecting Bacteria in CSF (Microscopy):
Due to the fragility of some bacterial species incriminated in CNS infections, CSF should be
Gram stained and examined microscopically at bed side, immediately after lumbar puncture
(Gray, 1992; Taha , 2004). Because the diagnostic usefulness of staining procedures depends
on the concentration of bacteria in the CSF of patients with bacterial meningitis (10 to 109
CFU/ml), all CSF specimens of sufficient quantity should be processed to concentrate
pathogens prior to microscopic examination and should be cultured as well (Gray, 1992;
Harris, 2003). However, in 30% to 40% of the bacterial meningitis cases, the Gram-stained
smear shows no bacteria (Ray et al., 2007). Gram stain and culture outcome is affected in
many clinical situations or may show negative results due to antibiotic therapy  before lumbar
puncture (Saravolatz, et al., 2003; Rafi, et al., 2010). Unfortunately, the yield of micro-
organism on Gram stain depends on factors like the number of organisms present, prior use of
antibiotics, technique of preparing slide and observer's skill (Das et al., 2003). Although CSF
Gram stain is quick, it is highly non-specific and often has a low sensitivity (Rafi et al., 2010).
Bacterial concentration in the CSF has a profound effect on the results of microscopy (Kim,
2010; Schuurman et al., 2004). Regardless of the type of organism in the CSF, the percentage
of positive microscopic results is only 25% with 10³ CFU/ml and 60% in the range of 103 to
105 CFU/ml (Schuurman, et al., 2004).
Examination of the CSF (biochemical finding and polymorph nuclear count) may be helpful
to differentiate between acute viral and acute bacterial meningitis (Taha, 2004).
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1.5.4. Serological tests for CSF analysis
Various other laboratory investigations of CSF have been developed for the rapid and specific
diagnosis of acute bacterial meningitis, mainly through detection of bacterial antigen by
immunological methods (Gray, 1992; Rafi et al., 2010). These tests alone, or in combination,
are limited by low sensitivities and specificities (Rafi et al., 2010). Latex Agglutination Test
(LAT) for detection of capsular antigens is a rapid test which is unlikely to be affected by
prior antibiotic therapy (Saravolatz et al., 2003; Rafi et al., 2010). Enzyme
Immunoassays_(EIAs) have been used also for the detection of bacterial antigens and bacteria
components in CSF (Gray, 1992). EIAs have been evaluated for their abilities to detect H.
influenzae type b, and N. meningitidis antigen in CSF (Gray, 1990). The sensitivities and
specificities of these tests have been reported to be (84-100) % and (89-100) % respectively
(Gray, 1990).
1.6 Molecular identification of Bacterial Meningitis:
Due to the limitations of other techniques (Gram, Cultural, specific-multiplex PCR), a
requirement for a robust detection method emerges (Corless et al., 2000). Recently,
polymerase chain reaction (PCR) -based assays have been considered as accurate diagnostic
tools (Chen et al., 2009; Cherian et al., 1998; Corless et al., 2000; Hall et al., 1995; Kotilainen
et al., 1998; Lorino et al., 1999; Lu et al., 2000; N. Margall, 2002; Reier-Nilsen et al., 2009;
Schuurman et al., 2004 ). PCR-based assays are the most sensitive of the existing rapid
methods to detect microbial pathogens in clinical specimens (Boisier et al., 2009; Chen et al.,
1989; Chen et al., 2009; Pandit et al., 2005). In recent years, PCR techniques have been
increasingly used to amplify and detect microbial DNA in cerebrospinal fluid for the diagnosis
of bacterial meningitis (Chen et al., 2009; Pandit et al., 2005). In particular, when specific
pathogens that are difficult to culture in vitro or requires a long cultivation period are expected
to be present in specimens, the diagnostic value of PCR is known to be significant
(Yamamoto, 2002; Tuyama et al., 2008 ; Kim, 2010; Barghouthi, 2009). With the introduction
of molecular techniques, live organisms are not required for detection or identification (Rafi et
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al., 2010). PCR methods are able to detect small amounts of pathogen including dead ones
(Sauer et al., 2005). Recent studies suggest that rapid detection systems can decrease the costs
associated with hospitalization and refine application of antibiotic treatment (Peterson, 2004;
Sauer et al., 2005). The administration of antibiotics to patients with suspected meningitis
before hospital admission and the collection of a cerebrospinal fluid (CSF) sample have
become common practice (Boving et al., 2009). This practice may correspondingly impair
microbiological diagnosis by culture of the bacteria responsible for the infection (Boving et
al., 2009). PCR has the potential for rapid diagnosis of bacterial meningitis while overcoming
the poor sensitivity of culture when antibiotic had been already introduced (Chakrabarti et al.,
2009) In bacterial meningitis, there is a good concordance between culture-positive and PCR-
positive patients (Pada et al., 2009).
1.7 Strategies used for PCR
There are different strategies to PCR amplification of bacterial DNA in clinical samples
(Sauer et al., 2005).
1.7.1. Specific Strategies
PCR-Based assays have become available to provide an early and accurate diagnosis of
bacterial meningitis; some of these assays are aimed at specific pathogens of bacterial
meningitis (Schuurman et al., 2004). This approach based on usage of species-specific primers
(Boving et al., 2009; Kim, 2010; Lu et al., 2000; Sauer et al., 2005). Unlike culture, most
molecular assays are designed specifically for specific number of organisms (Boving et al.,
2009; Elnifro et al., 2000; Harris, 2003; Henegariu et al., 1997; Taha, 2004). This provides
high sensitivity and specificity but detects only what you are looking for (Harris, 2003). This
method results in one of two possible outcomes; this method does not indicate the presence or
absence of other non-target bacterium. Therefore, it lacks the capacity to detect non-target
bacteria (Barghouthi, 2009; Lu et al., 2000; McCabe et al., 1999).
1.7.2. Multiplex approach:
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Similar to specific primer pairs, only specifically targets a number of pathogens (Boving, et
al., 2009). Multiplex is a mixture of primer pairs, each will specifically detect a single
pathogen (Henegariu et al., 1997). Similarly, multiplex will not detect any non-target
bacterium. The use of standard multiplex PCR has been shown to be useful in identification
of infecting pathogens in patients who have previously received antibiotics or in resource-poor
settings (Kim, 2010).
1.7.3. Universal Primer strategies:
The other approach uses broad-range bacterial PCR primers (Schuurman et al., 2004;
Barghouthi 2009; Boving, et al., 2009). PCR has been applied for the identification of
Neisseria meningitidis (Kristiansen et al., 1991; Ni H. et al., 1992; Seward, 2000), and for
simultaneous detection of Neisseria meningitidis, Streptococcus pneumoniae, and
Haemophilus influenzae as etiological agents of bacterial meningitis (Clarke, 2006; Diggle,
2006; Drakopoulou et al., 2008; Radstrom et al., 1994). However few reports have been
published evaluating the use of PCR amplification with universal primers on cerebrospinal
fluid samples taken from patients with meningitis (Greisen, et al., 1994; Radstrom, et al.,
1994; Hall, et al., 1995; Lu J.J et al., 2000; N. Margall, 2002). This approach involves
amplification of sequences found in all bacteria based on universal primers that target
sequences common to many bacteria (Barghouthi, 2009; Lu J.J et al., 2000; N. Margall et al.,
2002; Sauer et al., 2005; Sontakke et al., 2009). The universal primer approach is a misleading
hypothetical concept where there is no one primer pair is capable of detecting all bacteria
(Barghouthi 2009). Although the use of universal primes can detect many bacteria and may
detect bacteria that are found less frequently (Barghouthi, 2009). Broad-range assays, based on
ribosomal genes (rDNA), are designed to overcome species-specific primer limitations
(Harris, 2003). Bacterial (rDNA) contains conserved nucleotide sequences that are shared by
several bacterial species, interspersed with variable regions that are species-specific (Harris,
2003). 16S (rDNA) gene is widely used for taxonomic purposes (Clarridge, 2004). It is
possible to design PCR primers capable of amplifying all eubacteria based on the conservative
nature of the 16S ribosomal DNA (Barghouthi, 2009; Greisen et al., 1994; Lu et al., 2000;
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Radstrom, et al., 1994; Welinder-Olsson et al., 2007). The Universal Method was designed to
detect any bacterium (Barghouthi, 2009).
1.7.4. The Universal Method:
Most recently, a robust method developed by Barghouthi 2009, takes advantage of the
multiplex approach, probability, and conservative sequences of the 16S rDNA. A multiplex
known as G7 (previously primers mixture prepared by S.Barghouthi) has been tested and is
believed to detect any bacterium. The Universal Method offers a number of multiplex
mixtures that should yield positive PCR amplification with any bacterium. The Universal
Method (Barghouthi, 2009) had integrated several general primers, PCR amplification, DNA
sequencing, and sequence alignment (BLAST) in one system designed for the detection and
identification of  that bacterium (Barghouthi, 2009).
PCR can be used as a tool for the rapid detection of bacteria in normal sterile clinical samples
and, as such, would be useful in differentiating bacterial from viral infections (Barghouthi,
2009; Corless et al., 2000). This would confirm the necessity for antibiotic treatment and
would influence patient management (Corless et al. 2000). Several workers (Barghouthi, 2009;
Corless et al., 2000; Harris, 2003; Sauer et al., 2005) have used the 16S rDNA gene as a target
for bacterial detection. Strategic application of broad range primers has been found to be
superior to conventional techniques for detection of bacteria in sterile body fluids (Chakrabarti
et al., 2009). The use of PCR for rapid diagnosis of bacterial meningitis has the potential to
overcome the poor sensitivity of culture when antibiotic had been already introduced
(Chakrabarti et al., 2009). However, the relative risk of contamination remains the major
problem of using general and highly sensitive PCR alone as a specific test to confirm a
diagnosis (Chakrabarti et al., 2009). The specificity of broad range universal PCR has been
satisfactorily improved by further analysis of the PCR products by different methods
(Chakrabarti et al., 2009). The assay is valuable for initial screening to confirm or rule out
bacterial meningitis (Barghouthi, 2009; McCabe et al., 1999).
1.7.5. Sequencing of 16S ribosomal DNA:
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Since the development discovery DNA sequencing and PCR comparison of DNA sequences
loci of bacterial species shown that the 16S rDNA gene is highly suitable for phylogeny of
bacterial genera and species (Janda, 2007; Woo et al., 2003). For the previous reason it can be
used as the new “gold standard” for identification of bacteria to the species or genus level
(Janda and Abbott, 2007; Woo P.C. et al., 2003). Because 16S rDNA gene sequence analysis
can discriminate far more finely among bacterial species than is possible with phenotypic
methods, it can allow a more precise identification of poorly described, rarely isolated, or
phenotypically aberrant strains (Barghouthi, 2009; Clarridge, 2004; Drancourt et al., 2000;
Goldenberger et al., 1997). Unlike DNA which is highly stable, phenotypic features of a
bacterium fluctuate in response to environmental factors and time of assay (Barghouthi, 2009).
1.7.6. Limitations of molecular methods in the Diagnosis and Characterization of
bacteria:
The widespread use of molecular diagnostic tools may be hindered by cost and logistics,
particularly in developing countries (Taha, 2004) which is becoming a minor problem in
Palestine (Barghouthi, 2009). In universal strategies the risk of finding contamination is high
(Harris, 2003; Taha, 2004; Welinder-Olsson et al., 2007). There for using diluted samples
may be advantageous since it keeps contaminants below detection limits (Barghouthi, 2009).
The main weakness of specific strategies is that investigators can find only what they are
looking for (Henegariu, et al., 1997; Boving, et al., 2009; Barghouthi 2009). while missing
non-target bacteria (Barghouthi, 2009).
1.8 Treatment of bacterial meningitis:
Accurate diagnosis of bacterial infection leads to appropriate patient management, providing
information on prognosis and allowing the use of narrow-spectrum antibiotics (Gray, 1992;
Harris, 2003; Kim 2010). Eradication of the infecting organism from the CSF is entirely
dependent on antibiotics; bactericidal antibiotics should be administered intravenously at the
highest clinically validated doses to patients with suspected bacterial meningitis (Kim, 2010).
The antimicrobial agents played a pivotal role in the management and control of bacterial
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meningitis (Bergeron, 1998; Kim, 2003; Peterson, 2004). Usefulness of diagnostic tests would
be determine whether empirical antimicrobial therapy should or should not be administered
and thus potentially eliminate unnecessary administration of antimicrobial therapy to some
patients, reduces side-effects for the patient, saves money and may slow the spread of
antibiotic resistance (Berzanskyte et al., 2006; Harris, 2003; Saravolatz et al., 2003). The
common practice of antibiotic therapy prior to cerebrospinal fluid (CSF) evaluation coupled
with inconsistent laboratory support in developing countries hampers diagnosis (Pandit et al.,
2005). Because distinguishing between bacterial and viral meningitis in the emergency clinics
is difficult, it is recommended that antibiotics be started immediately in children with clinical
evidence of acute meningitis and/or cerebrospinal fluid (CSF) pleocytosis and continued at
least until bacterial diagnosis is made available (Dubos et al., 2008). These recommendation
of  empirical and early administration of antibiotics correlates with reduced rate of morbidity
and mortality, it is of crucial importance to initiate relevant and targeted prescribing treatment
as soon as possible (Levy, 2005; Dubos et al., 2008; Chakrabarti et al., 2009; Sontakke et al.,
2009). This urgency justifies the administration of broad-spectrum antibiotics to patients with
suspected meningitis before the collection of CSF or laboratory results become available
(Boving et al., 2009; Failace et al., 2005; Gray, 1992; Lu et al., 2000).
Optimizing diagnostic testing could differentiate true infection with pathogenic microbes
which are amenable to specific antimicrobial agent treatment and a clinical symptom complex
that does not require antimicrobial agent therapy (Grigoryan et al., 2007; Peterson, 2004). It
was found that patients were treated with broad-spectrum systemic antibiotics for suspected
bacterial meningitis bacterial infection, however, in only a small subset of treated cases leads
to the pathogen identification (Reier-Nilsen et al., 2009). A report from Spain  had found that
while only 22% of patients seeking medical care were clinically diagnosed as having an
infection in general, 67% were actually given antibiotics as a result of clinic visit (Peterson,
2004). The usefulness of any diagnostic test would be to determine whether empirical
antimicrobial therapy should or should not be administered and thus potentially eliminate
unnecessary administration of antimicrobial therapy to some patients (Saravolatz et al., 2003).
Perhaps the first molecular test that was successful in reducing antibiotic use because a
specific diagnosis could be rapidly made was the application of PCR to the detection of
enteroviral meningoencephalitis (Peterson, 2004; Saravolatz et al., 2003). Since these
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technologies do not require organism viability, and thus avoid any adverse effect of longer
specimen transport, they can be successfully applied to both the in- and outpatient settings
(Peterson, 2004).
Also, the resulting test rapidity theoretically will provide relevant information within a few
hours, which would limit any necessary empirical treatment to one or two doses (Peterson,
2004). Precise diagnosis can be the vital element in truly improving anti-infective prescribing
in cases of bacterial meningitis (Abasaeed et al., 2009; Boving et al., 2009; Grigoryan et al.,
2008; Kim, 2009; Lu J.J et al., 2000).
1.9 Literature review:
Detection and identification of bacterial meningitis using molecular techniques is fairly recent
approach which has highlighted the importance of the rapid diagnosis of bacteria in bacterial
meningitis (Duan et al., 2009; Tuyama et al., 2008). Currently, the diagnosis of meningitis is
mostly done by Microscopy of Gram stained CSF samples and culture (Chakrabarti et al.,
2009). Moreover CSF serology for detection of bacterial antigens is not widely practiced
because of its lower sensitivity and specificity compared to Gram stain and culture
(Chakrabarti et al., 2009).
A series of recent studies by Boving and Pederson have developed a system that uses species-
specific multiplex PCR focused on the bacterial and viral microorganisms most frequently
found in CSF (Boving et al., 2009). Multiplex real time PCR or broad-range PCR aimed at the
16S ribosomal RNA gene of eubacteria is promising for the detection of pathogens from CSF
(Boving et al., 2009; Kim, 2010).
A study by Ben and Kung et al. 2008, identified pathogens by using microarray or biochip; it
involves amplification of targeted DNA and hybridization of labeled DNA to specific
oliogonucleotide probes immobilized on a microarray (Ben et al., 2008; Kim, 2010).
However, its usefulness in clinical practice has been shown to be with low sensitivity as
microarray technique uses DNA probes from selected pathogens common to bacterial
17
meningitis, other pathogens or species (not incorporated on the microarray) cannot be detected
(Ben et al., 2008).
Another study carried out by Lu and coworkers designed one set of universal PCR primers and
claimed to amplify all bacteria (Lu.J.J et al., 2000). They have found that restriction enzyme
digestion patterns of the PCR produced with their universal primers differ from one bacterial
species to another. The results of this study, indicate that  PCR products followed by
restriction digestion is useful for rapid detection and identification of some bacterial
pathogens in cerebrospinal fluid, in this study the researchers used  { it was one pair , two
primers U1 and U2of primers only.(Lu .J.J et al., 2000).
Another recent study concerning rapid diagnosis of sepsis and bacterial meningitis in children
carried out by Chen and coworkers 2009 used Real-time Fluorescent quantitative PCR for 16S
rRNA gene. they introduced a fluorescent-labeled TaqMan probe into the PCR procedure
with a universal probe which aims to determine all of the common bacteria of meningitis
(Chen et al., 2009).
A typing approach was tested by Ceyhan and coworkers provides insight into the
pathogenesis of pneumococcal meningitis based on that Streptococcus pneumoniae as a major
cause of childhood acute bacterial meningitis in countries where vaccination against
Haemophilus influenzae type b and/or meningococcal disease has been implemented into the
routine immunization schedule. They performed a single-tube PCR assay for simultaneous
identification and targeting the gene ply for S. pneumoniae, then all positive samples were
tested using a multiple antigen detection assay capable of detecting 14 pneumococal serotypes
(Ceyhan et al., 2010).
In a study carried by Chiba and coworkers real time PCR  was develop  that can detect eight
pathogens; Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis,
Esherichia coli, Streptococcus agalactiae, and Staphylococcusaureus which they considered
as the major causative pathogens in neonatal meningitis; in addition to Listeria
monocytogenes and Mycoplasma pneumoniae, which are rarely the causative pathogens. They
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report an identification system using real-time PCR with pathogen-specific molecular (MB)
probes and primers for eight meningitis pathogens (Chiba et al., 2009).
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1.10. Study objectives:
Two major objectives are the focuses of this study:
1- Evaluation of the capability of the Universal Method (Barghouthi, 2009) for detecting
bacteria in clinical samples of CSF as a primary screening test for bacterial meningitis. This
general method will allow the detection of any bacterium with the potential for its subsequent
identification.
2- Construction of species specific multiplex with primers compatible with the Universal
Method thermocycler parameters for the detection of major etiological agents of bacterial
meningitis,  so that both PCR tests can be conducted simultaneously without any delay
1.11. Statement of the Problem:
Cultural methods used for bacterial detection are slow, insensitive, and inconclusive, whereas
molecular methods are fast, sensitive and specific. However, none of the current methods is
sufficiently sensitive to detect all bacterial CSF infections. The Universal Method developed
by Barghouthi 2009, is a potential candidate to detect any bacterium. This research is designed
to test the ability of the Universal Method to detect bacteria in 100-200µl of CSF. In addition,
this research will attempt to simultaneously identify the detected bacterial pathogen.
1.12. Hypothesis and Principle:
Bacterial meningitis may not be detected using conventional methods only especially using
cultural and specific primer multiplex techniques due to the wide spectrum of bacteria that can
cause bacterial meningitis. The detection of bacterial DNA in aseptically obtained clinical
samples collected in DNA free sterile tubes is sufficient to continue or stop antibacterial
therapy.
The procedure depends on the extraction of the bacterial DNA from the CSF specimen, then
applying the Universal Method and in parallel with the newly developed species specific PCR
Anchored Multiplex (AM) designed in this study. The amplified product is then used to
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identify the bacterial pathogen, directly from AM or after amplicon sequencing and BLAST
analysis as in published UM.
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Chapter 2: Materials and methods
In the present study, a robust method for detection and identification of bacterial meningitis is
developed. The method is a PCR based system that amplifies segments of 16S rDNA bacterial
gene allowing both detection and identification of CSF bacterial pathogens. Two methods are
applied simultaneously to each sample; The Universal Method golden primer mixture G7 and
the anchored species specific PCR multiplex (AM) has been used for simultaneous
identification  of the  most common causative agents of  bacterial meningitis: Streptococcus
pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and Listeria monocytogenes.
The assembly of general primer mixtures capable of amplifying 16S genes of bacteria
represent the key to successful application of the Universal Method (Barghouthi, 2009).
2.1 Patients
Clinical CSF samples were collected from 129 suspected meningitis patients by lumber
puncture, (neonates and internal word). All samples were tested by conventional methods
(culture). For this study, a duplicate sample was obtained from Al Ahli Hospital (H samples),
Alia Hospital (A samples), and Karetas Hospital (K samples) with appropriate permissions
between January 2009 and August 2010. Duplicate CSF samples were collected in DNA free
screw cap sterile microfuge tubes and stored at – 20 ºC.
2.2 Bacterial Reference Species, Control and Optimization of experiments:
The most common CSF bacteria (Neisseria meningitidis, Haemophilus influenzae,
Streptococcus pneumoniae, and Listeria monocytogenes were provided by Dr S.Barghouthi,
private bacterial collection in the form of pure cultures. DNA was extracted (see below) and
used fresh or stored frozen at -65˚C for further utilization.
2.3 DNA Extraction from pure bacterial cultures
To achieve a uniform DNA extraction procedure that is applicable to Gram positive and Gram
negative bacteria, the following protocol was performed:
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Water-mercaptoethanl mixture (V/V) was prepared (80:1) utilizing sterile distilled water and
2-mercaptoehanol (2ME; Sigma Chemicals). As a reducing agent, 2ME may inhibit or
inactivate bacterial enzymes such as proteases and nucleases that may interfere with the
quality of DNA or the efficiency of the PCR reaction. A 1µl sterile plastic loop was used to
transfer a loop-full of bacteria to 400 µl PBSWater-2ME, PBS is described below. After 5 min
of incubation at ambient room temperature, the bacterial cells were collected by centrifugation
at 13,000 rpm for 1min, supernatant was aseptically removed (discarded into a biohazard
container that was autoclaved before disposition). To the remaining pellet 50 µl of lysis
mixture (25 µl of 0.5N NaOH, and 25 µl of 1% Sodium Dodecyl Sulfate; SDS) were added,
mixed, and steamed over a boiling water bath for 10 min. The lysates were diluted with 150 µl
of sterile pure water, mixed, and centrifuged for 3 min at 13,000 rpm, the supernatant was then
used in PCR reactions. The remaining was transferred to a fresh sterile screw cap microfuge
and stored at -65˚C for further use.
2.4 Bacterial DNA Extraction from CSF samples
One hundred µl  of CSF sample  were placed in a labeled sterile screw cap microfuge tube: 0.5
µl of 2-mercaptoethanol (2ME) was added, after incubation at 37˚C for 5 min, centrifuged for
2 min at 13,000 rpm, supernatant was removed and appropriately discarded. The remaining
steps were exactly as described above (2.3 DNA Extraction from pure bacterial cultures).
2.4.1. Universal Method and Anchored-Multiplex PCR
The Universal Method was applied as described by Barghouthi 2009. Briefly, the golden
mixture multiplex (G7) which amplifies ten target sequences distributed among bacterial 16S
rDNA genes, which takes advantage of the probability of any one of those 10 sequence of
appearing in any bacterium. It  detects all bacteria and identifies  many bacterial species
(Barghouthi 2009). One of the produced PCR products is then sequenced for bacterial
identification through BLAST analysis of available DNA sequences in gene data bases.
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The anchored-multiplex (AM) method is a modified multiplex that was developed for this
study. A single general reverse primer that represents  most bacteria (particularly those
causing meningitis; (Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus
influenzae, Listeria monocytogenes, Staphylococcus aureus, and others) which was utilized by the
Universal Method  named (QUGP-Rn3) as illustrated with other primers in the shown 16S nucleotide
sequences Figure A, Appendix 1 . This primer (QUGP-Rn2 or Rn3) represents the anchor primer that
was mixed with four forward species specific primers (Table 2.1) that allowed the amplification of a
fixed length region of the target bacterium (Table 2.1).
Table:2.1 3General  primers mixtures (G7): The sequences of the general primers that is
contained in the G7 multiplex.
Table for primers of G7 multiplex
mixture
QUGP- Fn3 5’-CAGGATTAGATACCCTGGTAGTCC-3’
QUGP- F4 5’-CCGCCTGGGGAGTACG-3’
QUGP- Fn5 5’-ACTCCTACGGGAGGCAGCAG-3’
QUGP- Fn6 5’-CCAGCAGCCGCGGTAATAC-3’
QUGP- Rn1 5’-GGCTACCTTGTTACGACTTC-3’
QUGP- Rn2
QUGP- Rn3
5’-TGACGGGCGGTGTGTACAAG-3’
5’-GGCGTGGACTACCAGGGTATC-3’
2.4.2. Specific bacterial PCR identification
Four  primers designed to detect bacteria that is known to cause meningitis, a specific region
was selected from the 16S rDNA sequence according to the following steps:
 BLAST alignment of one selected rDNA sequence against all bacterial species selected
for the study (see primer Table (2.2), sizes and species).
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 Complete sequence of 16S ribosomal DNA for the most common bacteria that
commonly cause meningitis were downloaded. These included: Neisseria meningitidis,
Streptococcus pneumoniae, Haemophilus influenzae, Listeria monocytogenes. These
sequences were copied as Fasta format. When an oligonucleotide was selected it was
subjected to BLAST analysis, if it was unique to the target bacterium it was then
searched for in the rDNA string unit to determine its exact location (see Figure A,
appendix). The design of each primer took into consideration the PCR product size that
should identify that amplicon based on its size.
 The specificity of each band was achieved by designing a primer upstream  to the
location of the QUGP-Rn2 and QUGP-Rn3 that have been published earlier
(Barghouthi 2009) as general 16S PCR primers.
 For Every designed primer it was taken into consideration that Tm must be near 60ºC
as determined by the online Tm calculator
(http://www.promega.com/biomath/calcll.htm). A complete description for the primers
that were used in this study for amplification of conserved and specific regions of
bacteria commonly causing meningitis are shown (Table 2.2).
 A mixture containing the four specific forward primers and the QUGP-Rn3 was named
Anchored-Multiplex D4, since the QUGP-Rn3 or Rn2 served as the reference point to
determine the PCR product size. Species specific primers were also tested individually
with one of the general QUGPs primers as shown in Table (2.2).
 The primers designed  were from Metabion Co. - Germany.
2.4.3. Anchored-Multiplex D4
A mixture of the four primers was prepared in order to detect specific bacterial
pathogens. These were Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus
influenzae, Listeria monocytogenes, The concept of the anchored –multiplex takes
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advantage of the fact that the two reactions (G7 and AM) can be applied simultaneously
or sequentially. according to the following procedure:
1- 10 µl (100 pmol) from each forward  specific primer were mixed in one microfuge
tube
2- 40 µl (400 pmol) of the reverse primer (Rn2) was added
3- 20 µl of DNA- free water, this produced 10 pmol/ µl concentration of each primer,
except for the reverse primer which was used at 40 pmol to prevent its depletion in
case of the presence of more than one target sequence and to balance the 4 forward
primers.
4- This working mixture was diluted 10 times in the final PCR reaction.
2.4.4. PCR Mixture preparation
The PCR mixture was prepared according to the recipe listed below:
 PCR Reaction final volume 25.0 µl
 Master mix (Promega) 12.5 µl
 Forward primer (final quantity) 0.5 µl (5pmoles)
 Reverse primer (final quantity) 0.5 µl (5pmoles)
 Sterilized distilled water to 25.0 µl
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Table 2.2:4The sequences of the specific primers that were designed in this study and the
amplicon size for each
Primer PCR & Sequensing Primers
Tm
˚C
PCR  Product
Size with
QUGP-Rnn2
PCR Product
Size  QUGP-
Rn3
Listeria
monocytogenes
Digestion of
(TCCGGA)
5'-AAGTGTGGCGCATGCCACGCTT-3' 59˚C 1231 bp 631 bp(281+250)
Streptococcus
pneumoniae
Digestion of
(TCCGGA)*
5’-GTGTGAGAGTGGAAAGTTCACACTG-3’ 58˚C 952 bp
351 bp
102+249bp
Neisseria
meningitidis
5’-TTTGTCAGGGAAGAAAAGGCTGTTGC-
3’ 58˚C 969 bp
369 bp
Not digested
Haemophilus
influenzae 5’-TGAGAGGCCGCATGCCATAGGATGA-3’ 59˚C 1219bp
600 bp
Not Digested
2.4.5. Optimization of AMD4 Specificity :
The species specific primers which were used for the identification of Neisseria meningitidis ,
Haemophilus influenzae, Streptococcus pneumoniae, and Listeria monocytogenes were tested
against  known isolates preserved as stock cultures in our laboratory. Samples that produce
amplicons were shown to produce specific PCR band only when target DNA was provided
(Table 2.2). Pure cultures for the four bacterial species were stored and subcultured, DNA was
extracted and kept frozen to be used as  positive control in optimization experiments.
2.4.6 Optimization of AMD4 Sensitivity:
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To test the overall sensitivity of the multiplex,
 Bacterial colony was suspended in 1ml of phosphate saline buffer (PBS) which was
incubated for 5 minutes.
o PBS: Dissolve the following in 800ml distilled H2O.
▪ 80g of NaCl
▪ 2.0g of KCl
▪ 14.4g of Na2HPO4,
▪ 2.4g of KH2PO4, Adjust pH to 7.4, adjust volume to 1L with additional
distilled H2O, Sterilize by autoclaving.
 Serial dilution were prepared in CSF to presumably (estimated) 104 CFU/ml.
 100µ of 104 CFU were used to extract DNA as mentioned in section ( 2.2).
 In the DNA preparation process the sample was diluted by 2-fold ( 50µ lysis buffer and
150 µ water) and only 0.5 µ of DNA extract was used per PCR reaction.
 The estimated lower and upper limit of detection for the AMD4 was (12.5-1.25 CFU/ml),
2.5 PCR Thermocycler parameters and gel electrophoresis
A MiniCycler (MJ Research, Inc., Watertown, MA) heated lid thermocycler was used to
amplify target DNA. The amplification protocol was as following: Hot start at 95°C for
3minutes, followed by 30 cycles of denaturation at 94°C for 1:30 minutes, annealing at 60°C
for 1:30 minutes, extension at 72°C for 1:30°C, followed by a final extension step at 72°C for
3 minutes.
2.5.1. Agarose gel electrophoresis
Agarose gel was prepared as following:
1. 1.5% (w/v) agarose was prepared in 25 ml of 1X Tris-aceteat EDTA (TAE) buffer
(4.84 g Tris base, l.14 ml glacial acetic acid, and 2ml of 0.5M  EDTA, PH 8.0).
2. The agarose was boiled until dissolved. The agarose solution was cooled to about 50°C
and 5 µg of ethidium bromide was added.
28
3. The gel was casted in a tray 10x5 cm for electrophoresis, with comb in place. After
solidifying at room temperature, 1X TEA buffer was added into the electrophoresis
tank.
4. A size marker ladder 1Kbp (GeneDirex,USA ) or a 100pb-ladder was  applied to the
gel for  DNA sizing and band identification.
5. The gel was allowed to run for ~30 min at 120 volts, and then it was visualized under
UV light.
6. The gel was documented by photography using digital camera with sepia filter. The
size of DNA bands can be accurately determined.
2.6 Processing of cerebrospinal fluid samples
2.6.1. Identification of PCR product for positive CSF samples
2.6.1.1. Identification using species-specific multiplex PCR
The positive CSF samples that produced PCR by the AM (AMD4 mix) indicated one
of the four bacterial species included in the AM.
2.6.1.2. Bacterial identification using PCR product sequencing:
The positive samples that generated PCR product after UM detection but were negative
when using AMD4 were subjected to DNA sequencing according to the following
procedure: The NucleoSpin DNA and Gel purification kit was from MACHEREY-
NAGEL GmbH & Co. KG, Germany. The purification of the band was done according
to manufacturer instructions as following:
1. The agarose containing the DNA band to be purified was excised, using a flamed clean
scalpel. The slice was cut into several smaller pieces and transferred into to a pre-
weighed sterile 1.5 ml microcentrifuge tube, agarose slice was weighted to the
nearest 10 mg.
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2. The agarose was boiled until dissolved. The agarose solution was cooled to about 50°C
and 5 µg of ethidium bromide was added.
3. 0.5 ml of lysis buffer was added to the agarose slice, when dissolved, 0.5 ml of binding
buffer and 10 µl of suspension nucleo-trap were added.
4. The tube contents were mixed vigorously, heated at 55˚C allowing dsDNA to bind to
the solid phase matrix. (10 minutes).
5. After the double stranded DNA had bound to the binding matrix, it was collected by
centrifugation, washed in washing buffer, and eluted in a small volume (20-30 µl) of
sterile TE buffer. Checked for, presence, concentration,  and purity of purified band.
6. Stored at -20˚C until sequenced, alternatively if the PCR reaction contained a single
product, the product was purified directly from the PCR reaction without the need for
agarose electrophoresis.
2.7 Blast analysis:
BLAST (Basic local Alignment Search Tool) developed by Altschul (Altschul et al., 1990).
The program takes a query sequence and searches it against the database selected by the user.
It aligns a query sequence against every subject sequence in the database library by using
analysis software (Altschul et al., 1990; Clarridge, 2004). There are well-known databases of
16S rDNA gene sequences that can be consulted via the World Wide Web; such as GenBank
(http://www.ncbi.nlm.nih.gov/),the Ribosomal Database Project (RDP-II)
(http://rdp.cme.msu.edu/html/ ), the Ribosomal Database Project European Molecular Biology
Laboratory (http://www.ebi.ac.uk/embl/), Smart Gene IDNS (http://www.smartgene.ch),  and
Ribosomal Differentiation of Medical Microorganisms (RIDOM) (http://www.ridom.com/ ).
The proprietary MicroSeq 500 bacterial database (version 1.4.2) contains sequences for 1,434
species or subspecies within 235 genera (Clarridge, 2004). Once a sequence is BLAST
aligned, it can be judged if it is related, similar, or identical to any sequence that is deposited
in the sequence data base. If the sequence does not match (>97%) usually very little can be
said about the query sequence.
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Figure:(2.1) summarizes the working plan; it shows the steps of CSF sample processing from
DNA extraction to bacterial identification.
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Figure 2.1: 4 A working plan for sample processing steps from DNA extraction to
bacterial detection and identification
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Chapter 3: Results
3.1 Assay development
The mixture developed and adopted by the Universal Method; G7 amplify different regions of
the 16S rDNA gene. Comparison of these primers sequences with whole bacterial genomes
and available nucleotides in the different DNA databases shows that they are complementary
to a wide range of different bacterial genera and species. The theoretical broad-range of these
primers was validated by successful amplification of 101 different bacterial isolates at Al-
Quds University (Barghouthi, 2009).
3.2 Specificity of detection and identification procedures
The designed specific primers underwent a complete optimization for specificity using control
bacterial strains were provided by Karetas Hospital and from Barghouthi’s bacterial collection
(QUBC) by performing careful DNA extraction followed by amplification with species
specific primer alone. The results were as expected Fig. (3.1). The figure shows the calculated
PCR size products that are depicted in (Table 2.2). Neisseria meningitidis showing the
specific PCR band at 969bp, Haemophilus influenzae 1219bp, Streptococcus pneumoniae
925bp, and Listeria monocytogenes1231bp.
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Figure 3.1:5PCR products amplified using specific forward primers anchored to a
general reverse primer QUGP-Rn2, Optimization for each species specific primer.
Different lanes were PCR products from the following  control bacteria; Lane 1, N.
Meningitidis; lane 2, H. influenzae; Lane 3, S. pneumoniae; lane 4, L.monocytogenes. M
contained molecular size standards ladder (base pairs). The sizes of the molecular size
standards are indicated.
To test the performance of all four primers together, the anchored-multiplex D4 (AMD4) was
prepared as described in the methods section. AMD4 was applied to each individual
bacterium; the results of the PCR amplification are depicted in Fig. (3.2).
The results shown in Fig. (3.2), illustrate that AMD4 produced identical results as when
specific primers were applied individually, and that the results in Fig. (3.1) are identical to
those shown in Fig.(3.2). This shows high specificity to target DNA and shows no interference
between forward primers.
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Figure 3.2:6PCR products obtained using the AMD4 primer mix. with different bacterial
control Results. Lane1, N. meningitidis; lane 2, H. influenzae; Lane 3; S. pneumoniae; lane
4, L.monocytogenes; M contained molecular size standards ladder (base pairs).
3.3 Sensitivity of the detection and identification system
To test the sensitivity of detection of bacterial DNA, three negative CSF samples where spiked
with different dilutions of bacterial colonies of Neisseria meningitidis, Streptococcus
pneumoniae, Haemophilus influenzae, Bacterial DNA extraction was performed according to
the procedure mentioned in this study and bacterial DNA (1µ) was detected after (104 )
Neisseria meningitidis and Haemophilus influenzae and for Streptococcus pneumoniae (104),
when tested with AM4D Multiplex. As shown in Fig.(3.3), higher dilutions were not tested. L.
monocytogenes was not performed due to negative CSF sample availability.
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Figure 3.3:7Serially diluted bacterial colony, was used to spike negative CSF samples
with Neisseria meningitidis (104)CFU/ml, Haemophilus influenzae (104) CFU/ml and
Streptococcus pneumoniae (104) CFU/ml , DNA was extracted from CSF then amplified using
AM4D.
3.4 Detection of bacteria in clinical CSF samples and identification of positive samples:
A total of 129 CSF clinical samples (see methods), were analyzed by G7 multiplex mixture
which produced 126 negative samples and 3 positive samples Fig.(3.4), the other three
samples generated a PCR product which gave rise to similar general patterns Fig. (3.4).
Performance of these three positive samples with AMD4 resulted in one positive band
generated a PCR product of 969bp, according to Fig. (3.5) and Table (2.2) the bacterium was
identified as N. meningitidis. The other two G7-positive samples (H1 and A35) were negative
when tested with AMD4.
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Figure 3.4: 8Gel electrophoresis for bacterial detection in CSF positive samples: resulted
in three general PCR products using universal primers (G7) that indicated bacterial DNA
presence in the samples from three different hospitals, the other samples are negative.
Figure 3.5: Pilot experiment for N. meningitidis detection and identification: Lane 1,positive CSF sample,
Lane 2, detection of N. meningitidis using general primers of UM, Lane 3, identification of N.meningitidis by
species specific primer, Lane 4, identification of N.meningitidis using AM4D Species specific multiplex
CSF –ve
samples
CSF –ve
samples
CSF
–ve
samp.
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3.5 Identity of bacteria in H1 and A35 CSF Samples:
Sequencing of the two positive amplicons obtained from sample A35 and H1 resulted in two
rare types of bacteria that are not commonly identified by chemical tests or cultural methods
utilized by clinical laboratories. Sequencing of A35 and H1 revealed the sequences shown in
Figures (3.6), (3.7),( 3.8), and (3.9). As these sequences were analyzed using BLAST
alignment for query sequence, they showed no identity which could not be ascertained from
the BLAST results most likely due to the absence of these isolates from available bacterial
sequences and nucleotide databases. The BLAST alignments are shown in  Figure (3.10) and
Figure (3.11).
Although there is a high degree of similarity between A35 and H1 sequence Figure (3.12), it
should be noted that the two samples originated from two separate hospitals.
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Figure 3.6:9DNA sequence obtained for CSF sample A35; this sequence using forward primer QUGP- Fn6:
AGGGGCAGCGTTTATTCGGATTCTGGGCGTAAGGCGCGCGTAGGCGGAAATTAAGTCAGATGTGAAATCCCCGGGCTTAACCTGGGAACTGC
ATTTGATACTGGCTGGCTAGAGTGTGGGAGAGGGGAGTGGAATTCCCGGTGTAGCGGTGAAATGCGTAGATATGGGGAGGAACACCAGTGGC
GAAGGCGGCTCCCTGGGCCGATACTGACGCTGAGGCGCGAAAGCGTGGGGAGCAAA CAGGATTAGATACCCTGGTAGTCCACGCC
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Figure 3.7:10DNA sequence obtained for sample A35; this sequence using the reverse primer QUGP-Rn3 :
TTTCCTGTTTGCCTACCGCTTTCGCGCCTGCAGCGTCAGTAATGGGAAGGCAGGGAGCCGCTTGCCACTGGTGTTCCTCCCGATATTTACGCAT
TTCACCGCTACACCGGGAATTCCACTCCCCTCTGCCGTACTCTAGCCAGCCAGTTTCAAATGCAGTTCCCAGGTTGAGCCCGGGGATTTCACAT
CTGACTTAACTAACCGCCTACGCGCGCTTTACGCCCAGTAATTCCGATTAACGCTTGCACCCTTCGTATTACCGCGGCTGCTGGA
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Figure 3.8:11DNA sequence obtained for H1 CSF sample; this sequence using forward primer QUGP-Fn6:
GAGTCAGCGTTTTTTCCGAATTCTGGCGTAAGCGCGCGTAGGCGGAAATTAAGTCAGATGTGAAATCCCCGGGCTTAACCTGGGAACTGCATT
TGATACTGGCTGGCTAGAGTGTGGGAGAGGGGAGTGGAATTCCCGGTGTAGCGGTGAAATGCGTAGATATCGGGAGGAACACCAGTGGCGA
AGGCGGCTCCCTGGCCCGATACTGACGCTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCC
Figure 3.9:12Sequence obtained for sample H1; this sequence using the reverse primer QUGP-Rn3
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Figure 3.9: DNA sequence obtained for H1 CSF sample; this sequence using reverse  primer QUGP-Rn2:
AACCTGTTTGCTTACAGCTTTCGCGCCTGAGCGTCAGTAACTGGGACCAGGGAGCCGCCTCCGCCACTGGTGTTCCTCCCGATATCTACGCATT
TCACCGCTACACCGGGAATTCCACTCCCCTCTGCCGTACTCTAGCCAGCCAGTATCAAATGCAGTTCCCAGGTTGAGCCCGGGGATTTCACAT
CTGACTTAACTAACCGCCTACGCGCGCTTTACGCCCAGTAATTCCGATTAACGCTTGCACCCTTCGTATTACCGCGGCTGCTGG.
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Figure 3.10:13BLAST alignment for PCR product for positive CSF sample A35, using
the forward primer QUGP-Fn6 which resulted in Thioalkalivibrio sp HL-EbGR7 as the
closest match, complete genome.
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Figure 3.11:14BLAST Alignment for query sequence for positive CSF sample H1, using
forward primer QUGP- Fn6 which resulted in Thioalkalivibrio sp. HL-EbGR7, complete
genome
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Figure 3.12: 15The two sequences of A35 appears to be similar to H1 sequence with few
differences as indicated below. Reference boxes are indicated, some showing differences
between H1 and A35; First Box (GA-TTCTGGGCGTAA) &( GAATTCT-GGCGTAA)
indicating different sources of the two bacteria (A35 and H1) or Sequencing errors which
is unlikely since both forward and reverse sequencing produced sufficiently good
sequences.
3.6 Laboratory findings for CSF samples from conventional procedures
A total of 129 samples were analyzed by both conventional methods (in respective hospital
laboratory) and by UM G7 "broad range 16S rDNA PCR and AMD4 multiplex in Al-Quds
research laboratory and the results were as following :
3.7 Laboratory findings from broad-range 16S rDNA PCR
A total of 129 CSF samples were analyzed with UM and the specific AMD4 multiplex. Broad
range 16S rDNA based PCR could detect organisms among CSF samples. One case of N.
meningitidis could be identified by AM4D species specific PCR and the two others were
subjected to DNA sequencing, but BLAST analysis was not able to reveal the identities of
A35 and H1. The AMD4 were applied on those two samples and the results were negative.
The other 126 CSF Samples were negative by UM G7.
3.7.1. Discrepancies between culture and PCR testing
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The laboratories reported 128 samples to be negative, whereas UM-G7 reported 126 negative
samples. Two samples were found to be positive (A35 and H1). The CSF sample K1 which
was identified by the laboratory as N. meningitidis which was detected by both PCR methods;
UM-G7 and AMD4 put all three methods in complete concordance.
3.7.2. Overall performance of UM and AMD4:
Among the three UM-positive patients, patient (H1) was a healthy 3 year-old female who
presented to the hospital with a high fever (up to 39 ºC) and vomiting. After one blood sample
for culture was taken, the patient was given 1.5 g of Decort and 80 mg of vancomycin
intravenously in addition to Rocephen. The CSF finding was suggestive of bacterial
meningitis, but Gram staining revealed no microbes and the bacterial cultures were negative,
nonspecific diagnosis which was (No pathogenic growth) have been resulted from the
laboratory. The second patient (K1) which was diagnosed as bacterial meningitis caused by N.
meningitidis by conventional methods; it was in agreement with the results obtained by both
AMD4 and by UM G7 PCR. The third sample (A35) was from  a 4-year old patient presented
with fever, the culture results and gram stain were negative possibly due to treatment that had
started  prior to lumbar puncture. The CSF analysis indicated bacterial meningitis with high
white blood cell (WBC) counts and low sugar level. The UM G7 successfully detected the
bacterial presence in this sample (A35) even after antibiotic was introduced. Identification of
the bacterium after sequencing resulted in Thioalkalivibrio sp. (92% homology) Figure 3.10
and Figure (3.11).
The results suggest that unknown bacteria was present in each of (A35 and H1) CSF samples,
since the sequencing results were clean (both forward and reverse sequencing directions,
Figures ((3.6) –(3.7) –(3.8) –(3.9) ) and the BLAST results (figure 3.12) suggesting strong
similarity may exist between A35 an H1 (see discussion).
The two sequenced PCR for the samples ( A35 and H1) could not be identified, since the
accepted level of homology should be >97%. The identity of these bacteria ( A35 and H1)
remains obscure mostly because they have not been represented in the gene bank databases
yet. The results indicate that the two cases  of meningitis (A35 and H1) may have been caused
by unusual bacteria that is other than the > 1418 (Dec. 2010) bacteria available for BLAST
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analysis (see list at: http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) and the nucleotide
data base at
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?PROGRAM=blastn&BLAST_PROGRAMS=me
gaBlast&PAGE_TYPE=BlastSearch&SHOW_DEFAULTS=on&LINK_LOC=blasthome)
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Chapter 4: Discussion
The present study illustrates both the strengths and limitations of the broad range bacterial
detection and species specific PCR identification for bacterial meningitis.
The validation of broad range bacterial meningitis detection using general primers (Barghouthi
2009), in parallel with the development and validation of bacterial identification using species
specific multiplex mixture named as Anchored-Multiplex, AM4D which was designed and
prepared manually for this work. In previous study, the extremely robust ability of the
Universal Method G7 mixture to amplify 16S rDNA was found to be applicable and useful in
detecting bacteria in CSF. This work was in full agreement with the Universal Method. It was
also shown that this primers mixture is specific for bacterial DNA and doesn't amplify human
DNA. These features would allow The UM to be utilized with clinical CSF samples, and
possibly blood samples, where human DNA would certainly be present. The UM had
integrated several general primers, PCR amplification, DNA sequencing and bacterial
identification in one simple assay.
DNA sequence alignment (using BLAST); a single, simple, inexpensive, and efficient system
designed for the detection and identification of bacteria. The capacity and applicability of the
UM and primer mixture to detect bacteria was repeatedly demonstrated as described by
Barghouthi 2009. The detection and subsequent identification of novel bacterial species should
become a simple process especially when all known bacteria have been sequenced and
deposited in nucleotide data bases (Barghouthi, 2009).
The strength of the Broad rang detection assays is that it can test for the presence of a broad
panel of both bacterial agents and it can provide fast and reliable results, therefore it can be
used as a screening test (Barghouthi, 2009; Boving et al., 2009). This approach is valuable for
initial evaluation of the presence of bacteria when the specific pathogen is unknown, as in
“rule out meningitis” and assuming appropriate sensitivity, a negative amplification reaction
will indicate that no bacterial DNA is present. However, if a positive amplification is observed
then it will indicate the presence of bacterial DNA. In this case of positive results additional
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work will be required to identify the organism. The results show that the assay has a high
analytical sensitivity and specificity. This study and others (Barghouthi, 2009; Boving et al.,
2009; McCabe et al., 1999) have shown that, following  amplification of target bacterial DNA,
the target organism can be identified using species specific  primers; as in anchored-multiplex
D4, or by sequencing of the amplicon and subsequent nucleotide alignment (BLAST) against
available bacterial genomes. The method allows the identification of emerging or reemerging
bacterial pathogens, new pathogens, and even new encountered species. After antimicrobial
treatment is started, the chances of isolating bacteria from CSF are slim and cultures may
remain negative if the disease is caused by fastidious or slow growing microorganisms (Kim,
2010; Kotilainen et al., 1998) .
The morbidity and mortality associated with bacterial meningitis make meningitis a deadfall
illness for both physicians and patients. Therefore, fast, accurate, and inexpensive diagnosis
of bacterial meningitis will improve health provision while alleviating the worry associated
with suspicion of this disease (Kim, 2010; Saravolatz et al., 2003).
Efforts as improved the method of DNA isolation from bacteria including gram-positive
bacteria. During the present study it become apparent that the methods for preparing DNA
from a diversity of bacterial species, many of which are encapsulated, has a thick wall, or
other properties, require further improvement and additional preparation. In previous studies,
low analytical sensitivity may have been caused by problems associated with cell wall
cracking (Boving et al., 2009; Welinder-Olsson et al., 2007). These problems were solved by
combination of physical disruption (bead beating) and silica-guanidiniumthiocyanate
(Schuurman et al., 2004), such methods are long, problematic, and may cause contamination,
as well as they may require large sample size (which was 100µl of CSF in this study). In this
study, uniform DNA extraction was achieved using a modified procedure that entailed
pretreatment of bacteria or sample with 2- mercabtoethanol  at very low concentrations with
subsequent removal. As a reducing agent, 2ME may inhibit or inactivate bacterial enzymes
such as proteases and nucleases that may interfere with the quality of DNA or the efficiency of
the PCR reaction. The procedure was tested on cultured bacterial species separately, no
inhibition of the PCR reaction was observed under tested conditions. Several CSF samples
were also tested by this method, the applicability and reliability of the method was established.
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It is well known that implementation of molecular methods based on 16S rDNA or other
target genes can be hindered by problems with contamination of reagents or even samples to
be performed, which may be derived from any bacterial source. In this study, DNA free
microfuge tubes were used for the collection of CSF since several false positive results were
obtained when performing PCR on CSF samples collected in standard hospital tubes.
A total of 129 CSF samples were collected over one year (2009-2010) were examined, three
samples were positive by The UM, each of which generated a 16S PCR product. The
significance of the positive results is strengthened by the fact that aliquots of the same sample
were used for both the conventional and the molecular biological assay methods and there was
a complete opportunity for comparison between the study results and the conventional method
results performed by the source hospital laboratory on patients’ samples; the negative CSF
samples (126 samples) were negative by PCR and culture as well.
One of the three positive samples resulted in a unique PCR product size (969bp) that was
obtained with the N.meningitidis species specific PCR primers that was applied in the form of
anchored-multiplex D4, and it was in accordance with the hospital result of culture and PCR
identification. Fig (3.5).
The absence of Haemophilus influenzae infection among the tested sample, may be
explained by the fact that vaccination of all children against H.influenzae type b was
introduced, according to Boving et al., 2009, the rate of meningitis caused by this organism
has decreased by 97% (Boving et al., 2009). It worth mentioning that H.influnzae vaccine
was introduce in Palestinian public health care program (MOH) three years ago (2006) which
is in agreement with Boving et al. study in Denmark. Unfortunately, the meningococcal
meningitis vaccine has not been introduced yet, due to high cost (Referring to Ministry of
Health in Palestine, personal communication with Dr. A. Saffen). The meningococcal
quadrivalent (A,C,Y, and W-135) conjugate vaccine, Menactra was approved to be used in the
gulf states only recently (2010) http://www.ameinfo.com/235947.html.
The DNA sequences obtained for the other two positive samples were aligned, the DNA
BLAST analysis results indicated (BLASTN; www.ncbi.nlm.nih.gov). The identification of
two positive PCR purified DNA resulted in unique bacterial species that could not be
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determined based on available sequences, since 92% identity was observed, which is much
lower than the 97% cutoff value for species identity based on ribosomal DNA sequence.  The
two bacterial sequences could not be identified although they appeared to share high similarity
and have identified similar bacteria (~92%) homology; this indicated that the two isolates are
not represented by any related bacteria in the DNA data banks. No further conclusions can be
made. Whether they represent true bacterial infections or contaminations, or both cannot be
ascertained under the obtained data.
Although the results showed 126 negative samples and since the two samples were collected
from two different hospitals, both bacterial samples produced good DNA sequences (Figure:
(3.6)- (3.8).
Other positive CSF samples from Al Ahli hospital were not subjected to testing and were
rejected due to unsuitable collection and storage of CSF samples, those were: two positive S.
pneumonea, and 27 positive samples diagnosed as (No pathogenic growth). 570 CSF samples
with no bacterial growth, normal CSF analysis, normal Glucose and protein levels. Referring
to the patients files  in one of the hospitals (2009- 2010) indicated the low percentage of
bacterial infection in CSF even these patient are considered as suspected bacterial meningitis
admissions and received antibacterial therapy  while waiting for the culture results. In order to
do that, the Faculty of Health Professions coordinated with many hospitals in the region in
order to obtain as many samples as possible.
There are always common causes for every bacterial disease but usually, exceptions do exist,
because the species specific anchored-multiplex is limited to target species. The main
weakness of species specific PCR assays, is that investigators can only find the target
bacteria(what they are looking for ); they will not detect the presence or absence of non-target
bacteria (Boving et al., 2009). In a clinical setting, Gram staining and bacterial culture remains
the cornerstones of diagnosis. By adopting the Universal Method and the anchored multiplex
(D4), patients with negative infections can avoid unduly treatment, waiting, and expenses.
Another minor problem is that the PCR product sizes generated by AMD4 is due to
insufficient size difference (see table for PCR sizes of AMD4 products). We suggest that the
most suitable solution to this type of problem is the digestion of PCR products which was
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sequenced and found to be digested with any of the restriction enzyme  (BlfI, Bsp13I, Kpn2I,
BspMII, BsiMI, and  BseAI) that all recognize and cut the sequence 5’-TCCGGA-3’Such
digestion will cut  Listeria’s PCR product (631bp ) into 281+250 that can be easily
distinguished from the 600bp PCR product of Haemophilus influenzae. The same enzymes
can digest the PCR product of Streptococcus pneumoniae 351 into (102+249bp),
distinguishing it from the resistant PCR of 369 bp Neisseria meningitidis which is 369bp in
length, see Table (2.1).
Another way to solving this problem is tagging a selected forward primer with a GC clamp
that will cause the PCR to change size and allow its unambiguous separation by gel
electrophoresis; if a 30bp of GC clamp were added to the 5’- end of the N. meningitidis
specific primer making The PCR product appear as 399bp instead of 369bp setting it apart
from the 351 bp PCR product of Streptococcus pneumoniae. Similar primer modification can
be done with Listeria to increase its PCR product size to 661 instead of 631bp relative to that
of the Haemophilus influenzae which is 600bp (Val C. et al,. 1989).
In this study, it became obvious that species specific multiplex procedure have got limitations
in case of bacterial meningitis identification, since in this study two of three samples were
missed. The study supports the view that robust general detection methods of bacterial DNA
in CSF samples are superior to any other method. Especially in the context of high levels of
viral meningitis and absence of double infection (co-infections), see Tables (1.1) and (1.2).
The UM is an important tool as an initial screening test leading to identification of positive
samples before sequencing and BLAST analysis.
The most significant drawback of utilizing molecular and PCR technology in diagnosis is that
antibiotic profiling of the infectious agent cannot be assessed by simple techniques. However,
identification of the bacterium can improve the development of strategies to determine the
therapeutic drug and bacterial culturing techniques, such as creating a culture medium and
culturing conditions that are suitable for most pathogenic bacteria of the meninges and CNS.
The basic method to derive a sequence for a noncultured bacterium is to use PCR to amplify
the 16S rDNA gene then to sequence the amplicon (Barghouthi, 2009; Chen et al., 1989;
Clarridge, 2004; Rivers, 2001).
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The sensitivity of the assay should not significantly fluctuate just because the source of DNA
has changed as long as good quality DNA is obtained, accordingly, interest in sensitivity
should be shifted towards maximizing the utility of the CSF sample and the quality of
extracted DNA (Gray, 1992; Kim, 2003).
In this work, the species-specific anchored-multiplex D4 has proven compatible with the G7
of the UM, they both detected the presence of N. meningitides. This species is usually present
in CSF as low quantity of bacteria may reach to 103 CFU/ml(Gray, 1992).
The UM assay can be used as a valuable supplement to the traditional microscopy and culture
of CSF specimens in a routine diagnostic settings (Barghouthi, 2009). The anchored-multiplex
D4 is useful in eliminating or confirming the most encountered bacteria and should be applied
simultaneously with the UM G7 especially since both has compatible thermocycling
parameters. Molecular diagnosis of meningitis will eventually improve the patients’
management especially when clinical, microscopic and cultural methods are inconclusive. In
the present study, the universal method  which used a mixture of general  primers generating
up to 10 PCR products rather than one,  as proved in  other studies. This have enhanced the
ability and reliability of the UM to detect any bacterial DNA that may be found in CSF
samples; this study confirmed the compatibility and utility of the UM with CSF samples.
In conclusion, the assays described here, together with the modified DNA extraction protocol,
may be a valuable supplement to the traditional microscopy and culture of CSF specimens.
The use of this rapid and sensitive method will enable physicians to start treatment with
appropriate antimicrobial agents. On the long run, it is expected that new clinical-etiology of
meningitis should emerge as this method finds wider application. In this study, identifying
bacteria isolated in the clinical laboratory by sequence in combination  of phenotype can
improve clinical microbiology by better identifying poorly described, rarely isolated, or
biochemical aberrant strains. 16S rDNA gene sequences allow bacterial identification in a
robust manner, reproducible, and accurate than that obtained by phenotypic testing
(Barghouthi, 2009; Boving et al., 2009; Kim, 2010). It was also noticed that species specific
multiplex PCR is a limited procedure for bacterial identification even when the mixture
contains a high number of primers; especially since bacterial meningitis may result from a
multitude of species including Klebsiella, Clamedia, Acinitobacter, Staphylococcus aureus
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and others (Kim, 2010; Boving et al., 2009; Gray, 1992 ). This is demonstrated in the present
study; the two suspected bacteria of the two CSF samples (A35 and H1), see sequences in the
results section figures: (3.6)- (3.9). Hence, the advantages of 16S ribosomal DNA
amplification lie in the detection of non-culturable microorganisms or specimens rendered
sterile by prior antimicrobial therapy. Potentially, it can rapidly detect rare and fastidious
microorganisms (Boving et al., 2009; Kim, 2010; Pada et al., 2009).
Although there is a high degree of similarity between A35 and H1 sequences (Figure: (3.12),
the two samples originated from two separate hospitals. Contamination cannot be ruled out
even though when UM G7 produced 126 negative samples. Argument against the
contamination hypothesis is that the samples were not related; they both produced good DNA
sequencing results indicating the purity of the PCR amplicon hence the bacterium in each
sample which is usually unlikely when considering contamination. In addition to that, all
clinical signs of the two patients ( H1 and A35) were indicated bacterial meningitis infection.
See section( 3.7.2.).
Although the clinical parameters were not always consistent with the diagnosis of bacterial
meningitis, it was possible to detect infection using PCR (N. Margall, 2002). Moreover, the
use of nonradioactive primers allowed avoiding the danger of handling isotopes without losing
sensitivity (N.Margall, 2002).
To the best of our knowledge the present study is one of the first studies that adapt merging
between general and specific PCR techniques in order to detect and identify any bacterial
DNA in CSF samples. Furthermore, PCR is less affected by prior therapeutic regimen;
accordingly it can be useful for ruling out bacterial meningitis within few hours. Clinicians
could make informed decisions regarding the continuation or abortion of treatment in patients
suspected of having bacterial meningitis.
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ﻣﻠﺨﺺ ﺑﺎﻟﻌﺮﺑﯿﺔ
)ﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮي او اﻟﺘﮭﺎب اﻟﺪﻣﺎغ اﻟﺤﻤﻮي ھﻮ اﻟﺘﮭﺎب ﯾﺼﯿﺐ اﻟﻐﺸﺎء اﻟﻤﺒﻄﻦ ﻟﺴﻄﺢ اﻟﺪﻣﺎغ واﻟﺤﺒﻞ اﻟﺸﻮﻛﻲﻣﺮض ا
وان ﻛﺎن ﯾﻤﺜﻞ اﻻﻟﺘﮭﺎب اﻟﻔﯿﺮوﺳﻲ اﻟﻌﺪد اﻷﻋﻈﻢ ﻣﻦ ( أﺧﺮىأو ﻓﻄﺮي ﻓﻲ أﺣﯿﺎنوﯾﻜﻮن ﺑﺴﺒﺐ ﻓﯿﺮوﺳﻲ أو ﺑﻜﺘﯿﺮي
.ﺗﺼﻠﺐ اﻟﺮﻗﺒﺔوﺻﺪاع ﺷﺪﯾﺪ ، اﻟﻤﺸﺘﺮﻛﺔاﻷﻋﺮاض ﺗﺨﺘﻠﻒ ﻣﻦ ﺷﺨﺺ إﻟﻰ آﺧﺮ وﻟﻜﻦ ﺗﻮﺟﺪ ﺑﻌﺾ اﻷﻋﺮاض . اﻹﺻﺎﺑﺎت
ﯾﺼﺎﺣﺐ اﻟﺘﮭﺎب اﻟﺴﺤﺎﯾﺎ ﻋﻨﺪ اﻷﻃﻔﺎل اﻟﺼﻐﺎر اﻧﺘﻔﺎخ . ﻗﻲء وﺧﻤﻮل،ﯾﺘﻤﯿﺰ اﻟﻤﺮض ﺑﺄﻧﮫ ذو ﺑﺪء ﻓﺠﺎﺋﻲ أو ﺗﺪرﯾﺠﻲ، ﺣﻤﻰ
اﻟﯿﺎﻓﻮخ وﺗﺼﻠﺐ اﻟﺮﻗﺒﺔ واﻟﻈﮭﺮ ﻓﻲ اﻷﻃﻔﺎل اﻷﻛﺒﺮ ﻋﻤﺮا، وأﺣﯿﺎﻧﺎ ﺗﺤﺪث ﻏﯿﺒﻮﺑﺔ وﻗﺪ ﺗﺼﺎﺣﺒﮭﺎ ﺣﻤﻰ ﺧﻔﯿﻔﺔ ﻟﻌﺪة أﯾﺎم ﻣﻊ 
.اض اﻟﺘﮭﺎب اﻟﺠﮭﺎز اﻟﻌﺼﺒﻲ اﻟﻤﺮﻛﺰيﻇﮭﻮر أﻋﺮ
اﻟﺘﮭﺎب اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮي  ﻣﻦ اﻟﺨﻄﻮرة  ﺗﺠﻌﻠﮫ ﺳﺒﺒًﺎ ﺳﺮﯾﻌًﺎ ﻟﻠﻮﻓﺎة ﻓﻲ اﻷﺷﺨﺎص اﻷﺻﺤﺎء ذوي اﻟﻤﻨﺎﻋﺔ اﻟﺠﯿﺪة وﻟﻜﻦ ﻓﻲ 
وﻟﻜﻦ اﻟﺘﮭﺎب اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮﯾﺔ ﻣﻦ ﺟﮭﺔ . أﯾﺎم وﻣﻦ ﺛﻢ ﯾﺴﺘﻌﯿﺪ اﻟﻤﺮﯾﺾ ﺻﺤﺘﮫ٠١–٧ﻣﻌﻈﻢ اﻷﺣﯿﺎن ﯾﺴﺘﻤﺮ اﻟﻤﺮض ﻣﻦ 
اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮﯾﺔ ﺗﻌﺘﺒﺮ اﻗﻞ اﻧﺘﺸﺎرا و . ﻦ ﺷﻔﺎءھﺎ ﻣﻦ ﻏﯿﺮ اﻟﺘﺪﺧﻞ اﻟﻌﻼﺟﻲ وﻗﺪ ﯾﻨﺘﺞ ﻋﻨﮫ ﺗﻠﻒ اﻋﺎﻗﻲ أو وﻓﺎةأﺧﺮى ﻻ ﯾﻤﻜ
إﻻ أن ھﻨﺎك . (sitigninem airessieN)ﻟﻜﻨﮭﺎ اﺷﺪ ﺧﻄﻮرة و اﻟﺒﻜﺘﯿﺮﯾﺎ اﻟﺮﺋﯿﺴﯿﺔ اﻟﻤﺴﺒﺒﺔ ﻟﮫ ھﻲ اﻟﻤﻜﻮرات اﻟﺴﺤﺎﺋﯿﺔ 
)ياﻟﺮﺋﻮواﻟﻤﻜﻮرات ( )eazneulfni sulihpomeaHﻲﺑﻣﺴﺒﺒﺎت أﺧﺮى ﻻ ﺗﻘﻞ أھﻤﯿﺔ ﻣﺜﻞ اﻟﮭﯿﻤﻮﻓﻠﺲ 
airetseiLﻣﺜﻞ اﻟﻠﺴﺘﯿﺮﯾﺎﺑﺎﻻﺿﺎﻓﺔ اﻟﻰ اﻧﻮاع اﺧﺮى ﻣﻦ اﻟﺒﻜﺘﯿﺮﯾﺎ( eainomuenp succocotpertS
. اﻟﺘﻲ ﻗﺪ ﺗﺘﻤﻜﻦ ﻣﻦ اﻟﻮﺻﻮل اﻟﻰ ﺳﺎﺋﻞ اﻟﻨﺨﺎع اﻟﺸﻮﻛﻲوﻏﯿﺮھﺎ ﻣﻦ اﻟﺒﻜﺘﯿﺮﯾﺎ()senegotyconom
ﺼﺎدي اﻟﻤﺘﺪﻧﻲ وﻓﻲ ﻛﻞ اﻟﻔﺼﻮل، وﻟﻜﻦ ﺗﺰداد ﻣﻌﺪﻻت اﻟﺤﺪوث ﻓﻲ ﯾﺤﺪث اﻟﻤﺮض ﻋﺎدة ﻓﻲ اﻟﻤﺠﺘﻤﻌﺎت ذات اﻟﻤﺴﺘﻮى اﻻﻗﺘ
.ﻓﺼﻠﻲ اﻟﺸﺘﺎء واﻟﺮﺑﯿﻊ وﯾﺤﺪث ﻓﻲ ﺷﻜﻞ أوﺑﺌﺔ ﻓﻲ اﻟﺘﺠﻤﻌﺎت اﻟﻤﻐﻠﻘﺔ
ﯾﺘﻢ اﻟﺘﺸﺨﯿﺺ ﺑﺎﻟﻄﺮق اﻟﺘﻘﻠﯿﺪﯾﺔ ﺑﻮاﺳﻄﺔ ﻋﻤﻞ ﻣﺰرﻋﺔ ﻟﻌﺰل اﻟﺒﻜﺘﯿﺮﯾﺎ  ﻣﻦ ﺳﺎﺋﻞ اﻟﻨﺨﺎع اﻟﺸﻮﻛﻲ ﺛﻢ ﻓﺤﺺ ﻣﺠﮭﺮي ﻟﺸﺮﯾﺤﺔ 
.()marGﻣﺼﺒﻮﻏﺔ ﺑﻄﺮﯾﻘﺔ ﻏﺮام
ﻷي ﻃﻔﻞ  دون اﻟﺨﻤﺲ ﺳﻨﻮات وﻟﺪﯾﮫ أﻋﺮاض اﻟﺤﻤﻰ اﻟﺸﻮﻛﯿﺔ، ﻣﺜﻞ اﻟﺤﻤﻰ، اﻟﺼﺪاع، ﺗﺼﻠﺐ « ﻣﺸﺘﺒﮭﺔ»ﺤﺎﻟﺔ وﺗﻌﺘﺒﺮ اﻟ
ﻷي ﻃﻔﻞ دون اﻟﺨﺎﻣﺴﺔ  وﻟﺪﯾﮫ أﻋﺮاض ﺳﺮﯾﺮﯾﺔ ﻟﻠﺤﻤﻰ اﻟﺸﻮﻛﯿﺔ ﻣﻊ ﺳﺎﺋﻞ ﻧﺨﺎﻋﻲ « ﻣﺤﺘﻤﻠﺔ»وﺗﻌﺘﺒﺮ . اﻟﺮﻗﺒﺔ، اﻧﺘﻔﺎخ اﻟﯿﺎﻓﻮخ
، وﻧﻘﺺ ﻓﻲ ﻣﺴﺘﻮى (lm 001/gm 06 - 51)ﻲﺷﻮﻛﻲ ﻣﻌﻜﺮ، وارﺗﻔﺎع ﻣﻜﻮﻧﺎت اﻟﺒﺮوﺗﯿﻦ ﻓﻲ اﻟﺴﺎﺋﻞ اﻟﻨﺨﺎﻋﻲ اﻟﺸﻮﻛ
اﻟﺪم ﻋﻦ اﻟﻤﺴﺘﻮى اﻟﻄﺒﯿﻌﻲ اﻟﻤﺬﻛﻮر، ﻣﻊ ارﺗﻔﺎع ﻧﺴﺒﺔ  ﺧﻼﯾﺎ( )lm 001/gm 08 - 05اﻟﺴﻜﺮ ﻓﻲ اﻟﺴﺎﺋﻞ اﻟﻨﺨﺎﻋﻲ 
(.slihportueN)اﻟﻨﯿﺘﺮوﻓﯿﻞ اﻟﺒﯿﻀﺎء
اﻟﺸﻮﻛﯿﺔ ﻣﻊ وﺟﻮد ﻓﮭﻲ  ﻟﻠﻄﻔﻞ اﻟﺬي ﯾﻘﻞ ﻋﻤﺮه ﻋﻦ  ﺧﻤﺲ ﺳﻨﻮات وﻟﺪﯾﮫ أﻋﺮاض ﺳﺮﯾﺮﯾﺔ ﻟﻠﺤﻤﻰ « اﻟﻤﺆﻛﺪة»أﻣﺎ اﻟﺤﺎﻟﺔ 
اﻟﺒﻜﺘﯿﺮﯾﺎ اﻟﻤﻤﺮﺿﺔ ﻓﻲ ﻣﺰرﻋﺔ ﺳﺎﺋﻞ اﻟﻨﺨﺎع اﻟﺸﻮﻛﻲ أو اﻟﺘﻌﺮف ﻋﻠﻰ اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻟﻠﺠﺮﺛﻮﻣﺔ ﺑﻮاﺳﻄﺔ اﺧﺘﺒﺎر اﻟﻜﺮات 
.(TAL( )tseT noitanitulggA xetaL)ﺲﻻﺗﻜ
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ﺘﻮﺻﻞ اﻟﻰ اﻟﻨﻮع ﻓﻲ ھﺬه اﻟﺪراﺳﺔ ﺗﻢ اﻟﺘﻄﺮق اﻟﻰ اﻟﻜﺸﻒ اﻟﻤﺒﺪﺋﻲ ﻋﻦ وﺟﻮد أي ﻧﻮع ﻣﻦ اﻟﺒﻜﺘﯿﺮﯾﺎ ﻓﻲ ﺳﺎﺋﻞ اﻟﺴﺤﺎﯾﺎ  ﺛﻢ اﻟ
niahc esaremylop(RCP)اﻟﺒﻜﺘﯿﺮي اﻟﻤﺴﺒﺐ ﻟﻼﻟﺘﮭﺎب  وھﺬا ﻛﺎن ﺑﺎﺳﺘﺨﺪام  ﺗﻔﺎﻋﻞ اﻟﺒﻮﻟﯿﻤﯿﺮﯾﺰ اﻟﻤﺘﺴﻠﺴﻞ اﻟﻤﺘﻌﺪد 
lareneG(ﻌﺎﻣﺔاﻟﺒﺎدﺋﺎت اﻟﻣﺰﯾﺞ ﻣﻦﻣﺘﯿﻦ ﯾﺴﺘﺨﺪم ﻓﻲ اﻻوﻟﻰأوﻗﺪ ﺗﻜﻮن  اﻟﻔﺤﺺ ﻣﻦ ﻣﺮﺣﻠﺘﯿﻦ ﻣﺘﻮnoitcaer
و اﻟﺘﻲ ﺗﻌﻤﻞ ﻋﻠﻰ ﺗﻀﺨﯿﻢ ﻗﻄﻌﺔ ﻣﻦ )MU ()dohteM lasrevinU ehT ot gnieerefer 7G( ro )sremirp
ﺗﻌﺘﺒﺮ ﻣﮭﻤﺔ ﺟﺪا ﻟﻨﻔﻲ او اﺛﺒﺎت وﺟﻮد اﻻﻟﺘﮭﺎب اﻟﺒﻜﺘﯿﺮي و اﻟﺬي و ھﺬه اﻟﻤﺮﺣﻠﺔ (S61)AND lamosobiRاﻟﺠﯿﻦ
.ﺧﻄﻮرةﺷﺪﯾﻌﺘﺒﺮ اﻗﻞ اﻧﺘﺸﺎرا و ا
) sremirp cificeps seiceps(ﯾﺎت اﻟﺨﺎﺻﺔ ﺑﺄﻧﻮاع ﻣﻌﯿﻨﺔ ﻣﻦ اﻟﺒﻜﺘﯿﺮﺋﺎاﻣﺎ اﻟﺨﻄﻮة اﻟﺜﺎﻧﯿﺔ ﻓﺘﻌﺘﻤﺪ ﻋﻠﻰ ﻣﺤﻠﻮل ﻣﻦ اﻟﺒﺎد
واﻟﺘﻲ ﺗﺘﺴﺒﺐ  ﻋﺎدة ﺑﺎﻟﺘﮭﺎب اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮﯾﺎ وﻗﺪ ﺗﻢ ﺗﺤﻀﯿﺮ ھﺬا اﻟﻤﺤﻠﻮل و اﺧﺘﺒﺎره ﻛﺎﻣﻼ ﻓﻲ ﻣﺨﺘﺒﺮ ﺟﺎﻣﻌﺔ اﻟﻘﺪس  ﻋﻦ 
.()TSALBﻃﺮﯾﻖ  اﺳﺘﺨﺪام اداة ﺑﺤﺚ اﻻﺻﻄﻔﺎف اﻻﺳﺎﺳﯿﺔ 
ﺘﻲ ﻋﺎدة ﻣﺎ ﺗﺴﺒﺐ اﻟﻤﺮض و ﻗﺪ ﺗﻢ ﺗﻄﻮﯾﺮ ﻃﺮﯾﻘﺔ ﻋﻠﻰ اﻻﺻﻨﺎف اﻻﺳﺎﺳﯿﺔ ﻣﻦ اﻟﺒﻜﺘﯿﺮﯾﺎ و اﻟ()lortnoCﺗﻢ اﺧﺘﺒﺎر اﻟﻤﺤﻠﻮل 
ﻣﻦ ﻗﺪرﺗﮭﺎ ﻋﻠﻰ اﺳﺘﺨﺮاج ﻟﻠﺘﺄﻛﺪو اﺧﺘﺒﺎرھﺎ ﻟﻌﺪة ﻣﺮات ()noitcartxe ANDاﺳﺘﺨﺮاج اﻟﻤﺎدة اﻟﻮراﺛﯿﺔ اﻟﺒﻜﺘﯿﺮﯾﺔ 
زevitisop marG()و ﺧﺎﺻﺔ ﻣﻦ اﻟﺒﻜﺘﯿﺮﯾﺎ اﻟﻘﺎﺑﻠﺔ ﻟﻠﺼﺒﻐﺔ اﻟﻤﻮﺟﺒﺔ()ANDال
ﻣﻨﮭﺎ ﻧﺘﺎﺋﺞ ﺳﻠﺒﯿﺔ ﻟﻤﺮض اﻟﺴﺤﺎﯾﺎ ٦٢١ﺮﺣﻠﺘﻲ اﻟﺘﺴﺨﯿﺺ وﻗﺪ اﻋﻄﺖ ﻮﻛﻲ ﻟﻤﻋﯿﻨﺔ ﻣﻦ ﺳﺎﺋﻞ اﻟﻨﺨﺎع اﻟﺸ٩٢١ﺗﻢ اﺧﻀﺎع 
اﻟﺪراﺳﺔ ﺑﺤﯿﺚ اﻧﮭﺎ ﻧﻔﺖ و ﺟﻮد ﻣﺮض اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮي و ھﺬهاﻟﺒﻜﺘﯿﺮي ﺧﻼل ﺳﺎﻋﺎت ﻣﻌﺪودة و ھﺬا ﺑﺤﺪ ذاﺗﮫ ﯾﻤﺜﻞ اھﻤﯿﺔ 
()scitoibitna murtceps daorBﻋﺪم ﺗﻌﺮﯾﺾ اﻟﻤﺮﯾﺾ ﻟﺘﻌﺎﻃﻲ اﻟﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔ اﻟﻜﺎﻣﻠﺔ ادت ﺑﺎﻟﻨﺘﯿﺠﺔ اﻟﻰ ﺑﺎﻟﺘﺎﻟﻲ 
و ﺗﻌﺎﻃﻲ اﻟﻤﻀﺎدات  ﺑﺎﺳﺘﻤﺮار و ﺑﺪون و ﺟﻮد اﻟﺘﮭﺎب ﺑﻜﺘﯿﺮي ﯾﺆدي اﻟﻰ . ﻟﻠﻘﯿﺎم ﺑﺎﻟﻔﺤﺺﻌﺎدﯾﺔﻓﻲ ﺣﺎل اﻋﺘﻤﺎد اﻟﻄﺮﯾﻘﺔ اﻟ
ھﺬا ﻛﻠﮫ ﺑﺎﻻﺿﺎﻓﺔ اﻟﻰ .ﻟﺪى اﻟﺒﻜﺘﯿﺮﯾﺎ  و ﺑﺎﻟﺘﺎﻟﻲ ﻓﻘﺪان ﻓﺎﻋﻠﯿﺘﮭﺎ ﻣﺴﺘﻘﺒﻼ( )ecnatsiseRﺗﺸﻜﻞ ﻣﻘﺎوﻣﺔ ﻟﻠﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔ 
ﺎم ﻣﻜﻮﺛﮭﻢ ﻓﻲ اﻟﻤﺴﺘﺸﻔﻰ اﺛﻨﺎء اﻧﺘﻈﺎر ﻧﺘﺎﺋﺞ اﻟﺰراﻋﺔ ﻓﻲ ﺣﺎﻟﺔ اﻻﺷﺘﺒﺎه ﻓﻲ اﺻﺎﺑﺘﮭﻢ ﺑﺎﻟﺘﮭﺎب ﺗﻘﻠﯿﻞ ﻣﻌﺎﻧﺎة اﻟﻤﺮﺿﻰ و اﯾ
اﻟﻤﻜﻮرات اﻟﺴﺤﺎﺋﯿﺔ اﻣﺎ اﻟﻌﯿﻨﺎت اﻟﺜﻼﺛﺔ اﻟﺒﺎﻗﯿﺔ واﻟﺘﻲ اﻋﻄﺖ ﻧﺘﺎﺋﺞ اﯾﺠﺎﺑﯿﺔ ﻓﻜﺎﻧﺖ اﺣﺪاھﺎ ﺑﺴﺒﺐ . اﻟﺴﺤﺎﯾﺎ اﻟﺒﻜﺘﯿﺮي
و ﺗﻢ اﻟﺘﻌﺮف ﻌﺎدﯾﺔاﻟﻄﺮﯾﻘﺔ اﻟﺔ اﯾﻀﺎ ﺑﺎﺳﺘﺨﺪام ﺠﺘﯿﻦ اﻻﺧﺮﯾﯿﻦ اﻋﻄﺘﺎ ﻧﺘﺎﺋﺞ اﯾﺠﺎﺑﯿو اﻟﻨﺘﯿ( siditigninem airessieN)
ﺛﻢ اﺳﺘﺨﺪام ()gnicneuqeSﻋﻠﻰ ﺗﺴﻠﺴﻞ اﻟﻘﻮاﻋﺪ اﻟﻨﯿﺘﺮوﺟﯿﻨﯿﺔ ﻟﮭﺬه اﻟﻘﻄﻊ اﻟﻤﻀﺨﻤﺔ ﺑﺎﺳﺘﺨﺪام اﻟﺘﺤﻠﯿﻞ اﻟﺘﺴﻠﺴﻠﻲ اﻟﻤﺒﺎﺷﺮ 
.()TSALBاداة ﺑﺤﺚ اﻻﺻﻄﻔﺎف  اﻻﺳﺎﺳﯿﺔ 
ﻋﻦ ﻣﺮض اﻟﺘﮭﺎب اﻟﺴﺤﺎﯾﺎ )tset gnineercS(ﺗﺆﻛﺪ اﻟﺪراﺳﺔ ﻋﻠﻰ اھﻤﯿﺔ اﺳﺘﺨﺪام ﻃﺮق اﻟﺘﺸﺨﯿﺺ و اﻟﻜﺸﻒ
ﺿﻰ ﻛﻤﯿﺎت اﻟﺒﻜﺘﯿﺮﯾﺎ و ھﺬا ﺳﯿﺨﻔﻒ ﻣﻦ ﻣﻌﺎﻧﺔ اﻟﻤﺮﻷﻗﻞ)ytivitisnes(ي ﻣﻤﺎ ﻟﮫ ﻣﻦ ﺳﺮﻋﺔ ﻋﺎﻟﯿﺔ و ﺣﺴﺎﺳﯿﺔاﻟﺒﻜﺘﯿﺮ
وﺳﯿﻜﻮن ﻟﮭﺬﯾﻦ . ﻟﻠﻤﻀﺎدات اﻟﺤﯿﻮﯾﺔecnatsiseR()ﻣﻦ ﺣﺪوث ﻣﻘﺎوﻣﺔ ﻟﺪى اﻟﺒﻜﺘﯿﺮﯾﺎ ﺧﺎﺻﺔ اﻻﻃﻔﺎل ﻣﻨﮭﻢ ﻛﻤﺎ ﺳﯿﺨﻔﻒ 
.  ارة ﺗﺸﺨﯿﺺ و ﻋﻼج اﻟﻤﺮض  ﻣﺤﻠﯿﺎ وﻋﺎﻟﻤﯿﺎاﻻﻣﺮﯾﻦ اﻛﺒﺮ اﻻﺛﺮ  ﻓﻲ اد
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Appendices
A: Ribosomal DNA sequences and Primer Locations:
First location indicates species specific primers,
Second location is the QUGP-Rn3
Third location is the QUGP-Rn2
A-1 gi|16802048:243556 Listeria monocytogenes complete genome
CGAACGGAGGAAGAGCTTGCTCTTCCAATGTTAGTGGCGGACGGGTGAGTAACACGTGGGCAACCT
GCCTGTAAGTTGGGGATAACTCCGGGAAACCGGGGCTAATACCGAATGATAAAGTGTGGCGCATGC
CACGCTTTTGAAAGATGGTTTCGGCTATCGCTTACAGATGGGCCCGCGGTGCATTAGCTAGTTGGTA
GGGTAATGGCCTACCAAGGCAACGATGCATAGCCGACCTGAGAGGGTGATCGGCCACACTGGGAC
TGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCT
GACGGAGCAACGCCGCGTGTATGAAGAAGGTTTTCGGATCGTAAAGTACTGTTGTTAGAGAAGAAC
AAGGATAAGAGTAACTGCTTGTCCCTTGACGGTATCTAACCAGAAAGCCACGGCTAACTACGTGCC
AGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGATTTATTGGGCGTAAAGCGCGCGCAGG
CGGTCTTTTAAGTCTGATGTGAAAGCCCCCGGCTTAACCGGGGAGGGTCATTGGAAACTGGAAGAC
TGGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGATATGTGGAGGAA
CACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGCTGAGGCGCGAAAGCGTGGGGAGCAA
ACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGC
CCCTTAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGACCGCAAGGTTGAAACTC
AAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGA
ACCTTACCAGGTCTTGACATCCTTTGACCACTCTGGAGACAGAGCTTTCCCTTCGGGGACAAAGTGA
CAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCA
ACCCTTGATTTTAGTTGCCAGCATTTAGTTGGGCACTCTAAAGTGACTGCCGGTGCAAGCCGGAGGA
AGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATA
GTACAAAGGGTCGCGAAGCCGCGAGGTGGAGCTAATCCCATAAAACTATTCTCAGTTCGGATTGTA
GGCTGCAACTCGCCTACATGAAGCCGGAATCGCTAGTAATCGTGGATCAGCATGCCACGGTGAATA
CGTTCCCGGGCCTTGTACACACCGCCCGTCACACCACGAGAGTTTGTAACACCCGAAGTCGGTAGG
GTAACCTTTATGGAGCCAGCCGCCGAAGGTGGGACAGATAATTGGGGTGAAGTCGTAACAAGGTA
GCCGTATCGGAAGGTGCGGCTGGATCACCTCCTTTCT
A-2 gi|225857809:c1829303-1827846 Streptococcus pneumoniae 70585, complete genome
TGATCCTGGCTCAGGACGAACGCTGGCGGCGTGCCTAATACATGCAAGTAGAACGCTGAAGGAGGAGCTTGCT
TCTCTGGATGAGTTGCGAACGGGTGAGTAACGCGTAGGTAACCTGCCTGGTAGCGGGGGATAACTATTGGAAA
CGATAGCTAATACCGCATAAGAGTGGATGTTGCATGACATTTGCTTAAAAGGTGCACTTGCATCACTACCAGAT
GGACCTGCGTTGTATTAGCTAGTTGGTGGGGTAACGGCTCACCAAGGCGACGATACATAGCCGACCTGAGAGG
GTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCGGCAAT
GGACGGAAGTCTGACCGAGCAACGCCGCGTGAGTGAAGAAGGTTTTCGGATCGTAAAGCTCTGTTGTAAGAGA
AGAACGAGTGTGAGAGTGGAAAGTTCACACTGTGACGGTATCTTACCAGAAAGGGACGGCTAACTACGTGCCA
GCAGCCGCGGTAATACGTAGGTCCCGAGCGTTGTCCGGATTTATTGGGCGTAAAGCGAGCGCAGGCGGTTAGA
TAAGTCTGAAGTTAAAGGCTGTGGCTTAACCATAGTAGGCTTTGGAAACTGTTTAACTTGAGTGCAAGAGGGGA
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GAGTGGAATTCCATGTGTAGCGGTGAAATGCGTAGATATATGGAGGAACACCGGTGGCGAAAGCGGCTCTCTG
GCTTGTAACTGACGCTGAGGCTCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCTGTA
AACGATGAGTGCTAGGTGTTAGACCCTTTCCGGGGTTTAGTGCCGTAGCTAACGCATTAAGCACTCCGCCTGGG
GAGTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAAT
TCGAAGCAACGCGAAGAACCTTACCAGGTCTTGACATCCCTCTGACCGCTCTAGAGATAGAGTTTTCCTTCGGG
ACAGAGGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCG
CAACCCCTATTGTTAGTTGCCATCATTTAGTTGGGCACTCTAGCGAGACTGCCGGTAATAAACCGGAGGAAGGT
GGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGCTGGTACAACGAGTC
GCAAGCCGGTGACGGCAAGCTAATCTCTTAAAGCCAGTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTACATG
AAGTCGGAATCGCTAGTAATCGCGGATCAGCACGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCG
TCACACCACGAGAGTTTGTAACACCCGAAGTCGGTGAGGTAACCGTAAGGAGCCAGCCGC
A-3 gi|254804028:142152-143695 Neisseria meningitidis, complete genome
TGAACATAAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCATGCTTTACACATGCAAGTCGGACGGCAGC
ACAGAGAAGCTTGCTTCTTGGGTGGCGAGTGGCGAACGGGTGAGTAACATATCGGAACGTACCGAGTAGTGGG
GGATAACTGATCGAAAGATCAGCTAATACCGCATACGTCTTGAGAGAGAAAGCAGGGGACCTTTGGGCCTTGC
GCTATTCGAGCGGCCGATATCTGATTAGCTGGTTGGTGGGGTAAAGGCCTACCAAGGCGACGATCAGTAGCGG
GTCTGAGAGGATGATCCGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAAT
TTTGGACAATGGGCGCAAGCCTGATCCAGCCATGCCGCGTGTCTGAAGAAGGCCTTCGGGTTGTAAAGGACTTT
TGTCAGGGAAGAAAAGGCTGTTGCTAATACCAGCGGCTGATGACGGTACCTGAAGAATAAGCACCGGCTAACT
ACGTGCCAGCAGCCGCGGTAATACGTAGGGTGCGAGCGTTAATCGGAATTACTGGGCGTAAAGCGGGCGCAGA
CGGTTACTTAAGCAGGATGTGAAATCCCCGGGCTCAACCCGGGAACTGCGTTCTGAACTGGGTGACTCGAGTGT
GTCAGAGGGAGGTAGAATTCCACGTGTAGCAGTGAAATGCGTAGAGATGTGGAGGAATACCGATGGCGAAGG
CAGCCTCCTGGGACAACACTGACGTTCATGCCCGAAAGCGTGGGTAGCAAACAGGATTAGATACCCTGGTAGT
CCACGCCCTAAACGATGTCAATTAGCTGTTGGGCAACCTGATTGCTTGGTAGCGTAGCTAACGCGTGAAATTGA
CCGCCTGGGGAGTACGGTCGCAAGATTAAAACTCAAAGGAATTGACGGGGACCCGCACAAGCGGTGGATGATG
TGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATGTACGGAATCCTCCGGAGACGGAGGAGT
GCCTTCGGGAGCCGTAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG
CAACGAGCGCAACCCTTGTCATTAGTTGCCATCATTCAGTTGGGCACTCTAATGAGACTGCCGGTGACAAGCCG
GAGGAAGGTGGGGATGACGTCAAGTCCTCATGGCCCTTATGACCAGGGCTTCACACGTCATACAATGGTCGGT
ACAGAGGGTAGCCAAGCCGCGAGGCGGAGCCAATCTCACAAAACCGATCGTAGTCCGGATTGCACTCTGCAAC
TCGAGTGCATGAAGTCGGAATCGCTAGTAATCGCAGGTCAGCATACTGCGGTGAATACGTTCCCGGGTCTTGTA
CACACCGCCCGTCACACCATGGGAGTGGGGGATACCAGAAGTAGGTAGGATAACCGCAAGGAGTCCGCTTACC
ACGGTATGCTTCATGACTGGGGTGAAGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGCTGGATCACCTCCTT
TCT
A-4 gi|162960935:c311276-309738 Haemophilus influenzae 86-028NP, complete genome
AATTGAAGAGTTTGATCATGGCTCAGATTGAACGCTGGCGGCAGGCTTAACACATGCAAGTCGAACGGTAGCAGGAGAAAGC
TTGCTTTCTTGCTGACGAGTGGCGGACGGGTGAGTAATGCTTGGGAATCTGGCTTATGGAGGGGGATAACGACGGGAAACTGT
CGCTAATACCGCGTATTATCGGAAGATGAAAGTGCGGGACTGAGAGGCCGCATGCCATAGGATGAGCCCAAGTGGGATTAGG
TAGTTGGTGGGGTAAATGCCTACCAAGCCTGCGATCTCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAACTGAGACACG
GTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCGCAATGGGGGGAACCCTGACGCAGCCATGCCGCGTGAATGAAG
AAGGCCTTCGGGTTGTAAAGTTCTTTCGGTATTGAGGAAGGTTGATGTGATAATAGCACATCAAATTGACGTTAAATACAGAA
GAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCGAGCGTTAATCGGAATAACTGGGCGTAAAGGGC
ACGCAGGCGGTTATTTAAGTGAGGTGTGAAAGCCCTGGGCTTAACCTAGGAATTGCATTTCAGACTGGGTAACTAGAGTACTT
TAGGGAGGGGTAGAATTCCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAATACCGAAGGCGAAGGCAGCCCCTTGGG
AATGTACTGACGCTCATGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCTGTAAACGCTGTCGAT
TTGGGGGTTGGGGTTTAACTCTGGCGCCCGTAGCTAACGTGATAAATCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACT
CAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGA
CATCCTAAGAAGAGCTCAGAGATGAGCTTGTGCCTTCGGGAACTTAGAGACAGGTGCTGATGGCTGTCGTCAGCTCGTGTTGT
GAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGACTTGGTCGGGAACTCAAAGGAGACTGC
CAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCTCTTACGAGTAGGGCTACACACGTGCTACAATGGC
GTATACAGAGGGAAGCGAAGCTGCGAGGTGGAGCGAATCTCATAAAGTACGTCTAAGTCCGGATTGGAGTCTGCAACTCGAC
TCCATGAAGTCGGAATCGCTAGTAATCGCGAATCAGAATGTCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCA
66
CACCATGGGAGTGGGTTGTACCAGAAGTAGATAGCTTAACCTTTTGGAGGGCGTTTACCACGGTATGATTCATGACTGGGGTG
AAGTCGTAACAAGGTAACCGTAGGGGAACCTGCGGTTGGATCACCTCCTTA
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B: BLAST result with N. meningitidis and Thioalkalivibrio sp. HL-EbGR7
> ref|NC_011901.1| Thioalkalivibrio sp. HL-EbGR7, complete genome
Length=3464554
Features in this part of subject sequence:
rRNA-16S ribosomal RNA
Score = 1465 bits (793), Expect = 0.0
Identities = 1329/1576 (85%), Gaps = 83/1576 (5%)
Strand=Plus/Minus
Query 8        AAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCATGCTTTACACATGCAAGTCGGA 67
||||||||||||||||||||||||||||||||||||||||| | |||||||||||||| |
Sbjct 2549776  AAGAGTTTGATCCTGGCTCAGATTGAACGCTGGCGGCATGCCTAACACATGCAAGTCGAA 2549717
Query 68       CGGCAGCACAGAGAAGCTTGCTTCTTGGGTGGCGAGTGGCGAACGGGTGAGTAACATATC 127
||| |  |||| |  |||| |  |   | || ||||||||| |||||||||||||   |
Sbjct 2549716  CGGTA--ACAG-G-GGCTT-CGGC-CCGCTGACGAGTGGCGGACGGGTGAGTAACGCGTA 2549663
Query 128      GGAA-CGTACC-GAGTAGTGGGGGATAACT-GATCGAAAGATC-AGCTAATACCGCATAC 183
|||| | | || | || |||||||| |||| |   ||||  || ||||||||||||||||
Sbjct 2549662  GGAATC-TGCCTG-GTGGTGGGGGACAACTCG-GGGAAA-CTCGAGCTAATACCGCATAC 2549607
Query 184      GTCTTGA-GAGAGAAAGCAGGGGACCTTTGGGCCTTGCGCTATTCGAG-CG-GCC-GATA 239
| | | | | | |||||| ||||| ||| || ||| |||| | || ||  | ||| |
Sbjct 2549606  GCCCT-ACGGGGGAAAGCGGGGGATCTTCGGACCTCGCGCCA-TC-AGATGAGCCTG-CG 2549551
Query 240      TCTGATTAGCTGGTTGGTGGGGTAAAGGCCTACCAAGGCGACGATCAGTAGCGGGTCTGA 299
|| |||||||| ||||||||||||| |||||||||||||||||||| ||||| |||||||
Sbjct 2549550  TCCGATTAGCTAGTTGGTGGGGTAATGGCCTACCAAGGCGACGATCGGTAGCTGGTCTGA 2549491
Query 300      GAGGATGATCCGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGT 359
||||| |||| |||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct 2549490  GAGGACGATCAGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGT 2549431
Query 360      GGGGAATTTTGGACAATGGGCGCAAGCCTGATCCAGCCATGCCGCGTGTCTGAAGAAGGC 419
||||||| |||||||||||||| |||||||||||||| ||||||||||| ||||||||||
Sbjct 2549430  GGGGAATATTGGACAATGGGCGAAAGCCTGATCCAGCAATGCCGCGTGTGTGAAGAAGGC 2549371
Query 420      CTTCGGGTTGTAAAGGACTTT-TGTCAGGGAAGAAAAGGCTGTTGCTAATACCAG-CGGC 477
|| |||||||||||| |||||  || || ||||||||| |||  | ||||||| | |||
Sbjct 2549370  CTGCGGGTTGTAAAGCACTTTCAGT-AGAGAAGAAAAGCCTGGCGTTAATACC-GTCGGG 2549313
Query 478 TGATGACGGT-ACCTGA-AGAATAAGCACCGGCTAACTACGTGCCAGCAGCCGCGGTAAT 535
|  |||| || |||| | |||| ||||||||||||||| |||||||||||||||||||||
Sbjct 2549312  TCTTGAC-GTAACCT-ACAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAAT 2549255
Query 536      ACGTAGGGTGCGAGCGTTAATCGGAATTACTGGGCGTAAAGCGGGCGCAGACGGTTAC-T 594
||| ||||||| |||||||||||||||||||||||||||||||  || || |||   | |
Sbjct 2549254  ACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGTAGGCGG--CCTT 2549197
Query 595 -TAAG-CAGGATGTGAAATCCCCGGGCTCAACCCGGGAACTGCGTTCTGA-ACTG--GGT 649
|||| | |||||||||| ||||||||| |||| ||||| |||  || || ||||  ||
Sbjct 2549196  GTAAGTC-GGATGTGAAAGCCCCGGGCTTAACCTGGGAATTGC-ATCCGATACTGCAGG- 2549140
Query 650      GACTCGAGTGT-GTCAGAGGGAG-GTAGAATTCCAC-GTGTAGCAGTGAAATGCGTAGAG 706
| || |||| | || ||| |||| || ||||||| | ||||||| ||||||||||||||
68
Sbjct 2549139  G-CTAGAGTTTGGT-AGA-GGAGAGTGGAATTCC-CGGTGTAGCGGTGAAATGCGTAGAT 2549084
Query 707      AT-GTGGAGGAATACCGA-TGGCGAAGGCAGCCTC-CTGGGA-CAACACTGACGTTCATG 762
|| | ||||||| ||| | |||||||||| | ||| || ||| ||| ||||||| | | |
Sbjct 2549083  ATCG-GGAGGAACACC-AGTGGCGAAGGC-GACTCTCT-GGACCAAAACTGACGCTGAGG 2549028
Query 763      CCCGAAAGCGTGGGTAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATG 822
|||||||||||| ||||||||||||||||||||||||||||||||||| |||||||||
Sbjct 2549027  TGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATG 2548968
Query 823      TCAATTAGCTGTT-GG-GCAACCTGATTGCTTGGTAGCGTAGCTAACGCGTGAAATTGAC 880
|| |||| ||| || | |   ||  | ||| || ||| ||||||||| | || ||  |
Sbjct 2548967  AGAACTAGCCGTTGGGAGGATTATGCCT-CTTAGTGGCGCAGCTAACGCATTAAGTTCTC 2548909
Query 881      CGCCTGGGGAGTACGGTCGCAAGATTAAAACTCAAAGGAATTGACGGGGACCCGCACAAG 940
|||||||||||||||| |||||| || |||||||||||||||||||||| ||||||||||
Sbjct 2548908  CGCCTGGGGAGTACGGCCGCAAGGTTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAG 2548849
Query 941      CGGTGGATG-ATGTGGATTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACAT- 998
||||||| | |||||| ||||||||||||||||||||||||||||||||  ||||||||
Sbjct 2548848  CGGTGGA-GCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGCCCTTGACATC 2548790
Query 999      GTACGGAATCCT-CCGGAGACGGA--GGAGTGCCTTCGGGAGCCGTA-ACACAGGTGCTG 1054
| ||||| | |  | ||||  ||   | |||||||||||| ||| |   ||||||||||
Sbjct 2548789  CT-CGGAA-CTTGTCAGAGA-TGACTTG-GTGCCTTCGGGAACCG-AGTGACAGGTGCTG 2548735
Query 1055     CATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACC 1114
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct 2548734  CATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACC 2548675
Query 1115     CTTGTCATTAGTTGCCATCA-TTCAGTTGGGCACTCTAATGAGACTGCCGGTGACAAGCC 1173
||||||  ||||||||| || ||| | |||| ||||||  ||||||||||||||||| ||
Sbjct 2548674  CTTGTCCCTAGTTGCCAGCACTTCGGGTGGGAACTCTAGGGAGACTGCCGGTGACAAACC 2548615
Query 1174     GGAGGAAGGTGGGGATGACGTCAAGTCCTCATGGCCCTTATGACCAGGGCTTCACACGT- 1232
||||||||||||||||||||||||||| ||||||||||||||  ||||||| |||||||
Sbjct 2548614  GGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTATGGGCAGGGCTACACACGTG 2548555
Query 1233     CATACAATGGTCGGTACAGAGGGTAGCCAAGCCGCGAGGCGGAGCCAATCTCACAAAACC 1292
| |||||||| | ||||||||||| ||||| |||||||| |||||||||| || ||| |
Sbjct 2548554  C-TACAATGGCCAGTACAGAGGGTTGCCAACCCGCGAGGGGGAGCCAATCCCAGAAAGCT 2548496
Query 1293     GATCGTAGTCCGGATTGCACTCTGCAACTCGAGTGCATGAAGTCGGAATCGCTAGTAATC 1352
| ||||||||||||||| | |||||||||||| | |||||||||||||||||||||||||
Sbjct 2548495  GGTCGTAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATC 2548436
Query 1353     GCAGG-TCAGCATA-CTGCGGTGAATACGTTCCCGGGTCTTGTACACACCGCCCGTCACA 1410
|| || |||||||  | |||||||||||||||||||| ||||||||||||||||||||||
Sbjct 2548435  GC-GGATCAGCATTGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACA 2548377
Query 1411     CCATGGGAGTGGGG-GATACCAGAAGTAGGTAGGATAACCG-CAAGGAGTCCGCTTACCA 1468
|||||||||| ||  |  ||||||||||| |||  |||||  |  ||||  || ||||||
Sbjct 2548376  CCATGGGAGTTGGCTGC-ACCAGAAGTAGATAGTCTAACCTTCG-GGAGGACGTTTACCA 2548319
Query 1469     CGGTATGCTTCA-TGACTGGGGTGAAGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGC 1527
|||| || | || |||||||||||||||||||||||||||||||||||||||||||||||
Sbjct 2548318  CGGTGTGGT-CAATGACTGGGGTGAAGTCGTAACAAGGTAGCCGTAGGGGAACCTGCGGC 2548260
Query 1528     TGGATCACCTCCTTTC 1543
||||||||||||||||
Sbjct 2548259  TGGATCACCTCCTTTC 2548244
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